1
|
Wang YM, Liu YS, Li J, Zhang Q, Yan TT, Ren DF, Zhu L, Zhang GY, Yang Y, Liu JF, Chen TY, Zhao YR, He YL. [Prognostic nutritional index application value for acute-on-chronic liver failure co-infection]. Zhonghua Gan Zang Bing Za Zhi 2024; 32:235-241. [PMID: 38584105 DOI: 10.3760/cma.j.cn501113-20240109-00021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/09/2024]
Abstract
Objective: To explore the predictive value of the prognostic nutritional index (PNI) in concurrently infected patients with acute-on-chronic liver failure (ACLF). Methods: 220 cases with ACLF diagnosed and treated at the First Affiliated Hospital of Xi'an Jiaotong University from January 2011 to December 2016 were selected. Patients were divided into an infection and non-infection group according to whether they had co-infections during the course of the disease. Clinical data differences were compared between the two groups of patients. Binary logistic regression analysis was used to screen out influencing factors related to co-infection. The receiver operating characteristic curve was used to evaluate the predictive value of PNI for ACLF co-infection. The measurement data between groups were compared using the independent sample t-test and the Mann-Whitney U rank sum test. The enumeration data were analyzed using the Fisher exact probability test or the Pearson χ(2) test. The Pearson method was performed for correlation analysis. The independent risk factors for liver failure associated with co-infection were analyzed by multivariate logistic analysis. Results: There were statistically significant differences in ascites, hepatorenal syndrome, PNI score, and albumin between the infection and the non-infection group (P < 0.05). Among the 220 ACLF cases, 158 (71.82%) were infected with the hepatitis B virus (HBV). The incidence rate of infection during hospitalization was 69.09% (152/220). The common sites of infection were intraabdominal (57.07%) and pulmonary infection (29.29%). Pearson correlation analysis showed that PNI and MELD-Na were negatively correlated (r = -0.150, P < 0.05). Multivariate logistic analysis results showed that low PNI score (OR=0.916, 95%CI: 0.865~0.970), ascites (OR=4.243, 95%CI: 2.237~8.047), and hepatorenal syndrome (OR=4.082, 95%CI : 1.106~15.067) were risk factors for ACLF co-infection (P < 0.05). The ROC results showed that the PNI curve area (0.648) was higher than the MELD-Na score curve area (0.610, P < 0.05). The effectiveness of predicting infection risk when PNI was combined with ascites and hepatorenal syndrome complications was raised. Patients with co-infections had a good predictive effect when PNI ≤ 40.625. The sensitivity and specificity were 84.2% and 41.2%, respectively. Conclusion: Low PNI score and ACLF co-infection have a close correlation. Therefore, PNI has a certain appraisal value for ACLF co-infection.
Collapse
Affiliation(s)
- Y M Wang
- Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China Shaanxi Clinical Research Center for Infectious Diseases, Xi'an 710061, China Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| | - Y S Liu
- Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China Shaanxi Clinical Research Center for Infectious Diseases, Xi'an 710061, China Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| | - J Li
- Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China Shaanxi Clinical Research Center for Infectious Diseases, Xi'an 710061, China Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| | - Q Zhang
- Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China Shaanxi Clinical Research Center for Infectious Diseases, Xi'an 710061, China Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| | - T T Yan
- Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China Shaanxi Clinical Research Center for Infectious Diseases, Xi'an 710061, China Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| | - D F Ren
- Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China Shaanxi Clinical Research Center for Infectious Diseases, Xi'an 710061, China Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| | - L Zhu
- Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China Shaanxi Clinical Research Center for Infectious Diseases, Xi'an 710061, China Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| | - G Y Zhang
- Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China Shaanxi Clinical Research Center for Infectious Diseases, Xi'an 710061, China Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| | - Y Yang
- Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China Shaanxi Clinical Research Center for Infectious Diseases, Xi'an 710061, China Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| | - J F Liu
- Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China Shaanxi Clinical Research Center for Infectious Diseases, Xi'an 710061, China Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| | - T Y Chen
- Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China Shaanxi Clinical Research Center for Infectious Diseases, Xi'an 710061, China Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| | - Y R Zhao
- Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China Shaanxi Clinical Research Center for Infectious Diseases, Xi'an 710061, China Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| | - Y L He
- Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China Shaanxi Clinical Research Center for Infectious Diseases, Xi'an 710061, China Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| |
Collapse
|
2
|
Li TY, Zhang YL, Zhou XL, Li B, Liu JF. [Advancements in the research of congenital anosmia]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2024; 59:180-186. [PMID: 38369800 DOI: 10.3760/cma.j.cn115330-20231010-00135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 02/20/2024]
Affiliation(s)
- T Y Li
- Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - Y L Zhang
- Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - X L Zhou
- Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - B Li
- Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - J F Liu
- Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| |
Collapse
|
3
|
Zhao CQ, Sun XC, Wan YZ, Ye J, Tan GL, Liu JF, Wang YJ, Cheng FL, An YF. [The principle and practice of vidian neurectomy]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2024; 59:51-56. [PMID: 38212135 DOI: 10.3760/cma.j.cn115330-20231010-00129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 01/13/2024]
Abstract
The latest research findings on bidirectional regulation of neuro-immunity through traditional neural circuits shed new light on the theoretical basis of the role of vidian neurectomy (VN). This article aims to provide a comprehensive understanding of VN, including the history of VN, the principle of neuroimmuno-interaction, the applied anatomy of VN as well as the methods of transnasal endoscopic surgery. Additionally, we introduce the concept of the nose-brain axis, which was proposed based on the advancement in the area of neuro-immune interactions.
Collapse
Affiliation(s)
- C Q Zhao
- Department of Otorhinolaryngology Head and Neck Surgery, the Second Hospital, Shanxi Medical University, Taiyuan 030000, China
| | - X C Sun
- Department of Otorhinolaryngology, Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai 200031, China
| | - Y Z Wan
- Department of Otorhinolaryngology Head and Neck Surgery, Shandong Provincial ENT Hospital, Shandong University, Jinan 250022, China
| | - J Ye
- Department of Otorhinolaryngology Head and Neck Surgery, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - G L Tan
- Department of Otorhinolaryngology Head and Neck Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, China
| | - J F Liu
- Department of Otorhinolaryngology, China-Japan Friendship Hospital, Beijing 100029, China
| | - Y J Wang
- Department of Otorhinolaryngology Head and Neck Surgery, the Second Hospital, Shanxi Medical University, Taiyuan 030000, China
| | - F L Cheng
- Department of Otorhinolaryngology Head and Neck Surgery, the Second Hospital, Shanxi Medical University, Taiyuan 030000, China
| | - Y F An
- Department of Otorhinolaryngology Head and Neck Surgery, the Second Hospital, Shanxi Medical University, Taiyuan 030000, China
| |
Collapse
|
4
|
Yan S, Tu CY, Du CY, Luo J, Liu JF, Liu TQ, Liu Q, Liu J, Li XH, Wang LC, Fang ZP, Yi WM, Chen YJ, Li QL, Ni Y, Wu JC, Qin CJ, Gu YL, Lu Z, Lun ZJ, Du LX, Chen G, Zheng QC, Sun KJ, Han WQ, Yu J. [Effect of recombinant human thrombin for hemostasis in liver resection: a randomized controlled phase Ⅲ clinical trial]. Zhonghua Yi Xue Za Zhi 2023; 103:3416-3423. [PMID: 37963740 DOI: 10.3760/cma.j.cn112137-20230911-00438] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 11/16/2023]
Abstract
Objective: To evaluate the hemostatic efficacy, safety and immunogenicity of recombinant human thrombin in the treatment of liver wounds that still ooze after conventional surgical hemostasis. Methods: A multicenter, stratified randomized, double-blind, placebo-controlled phase Ⅲ trial with a planned enrollment of 510 subjects at 33 centers, with a 2∶1 randomization to the thrombin group versus the placebo group. An interim analysis will be conducted after approximately 70% of the subjects have completed the observation period. The primary efficacy endpoint was the rate of hemostasis within 6 minutes at the point of bleeding that could be evaluated. Safety analysis was performed one month after surgery, and the positive rates of anti-drug antibody (ADA) and neutralizing antibody were evaluated. Results: At the interim analysis, a total of 348 subjects had been randomized and received the study drug (215 were male and 133 were female). They were aged 19-69 (52.9±10.9)years. Among them, 232 were in the thrombin group and 116 were in the placebo group, with balanced and comparable demographics and baseline characteristics between the two groups. The hemostasis rate at 6 minutes was 71.6% (95%CI:65.75%-77.36%) in the thrombin group and 44.0% (95%CI: 34.93%-53.00%) in the placebo group, respectively (P<0.001). No grade≥3 drug-related adverse events and no drug-related deaths were reported from the study.No recombinant human thrombin-induced immunologically-enhanced ADA or immunologically-induced ADA was detected after topical use in subjects. Conclusion: Recombinant human thrombin has shown significant hemostatic efficacy and good safety in controlling bleeding during liver resection surgery, while also demonstrating low immunogenicity characteristics.
Collapse
Affiliation(s)
- S Yan
- Department of Hepatobiliary and Pancreatic Surgery, the Second Hospital of Zhejiang University School of Medicine, Hangzhou 310003, China
| | - C Y Tu
- Department of General Surgery, Lishui Central Hospital, Lishui 323020, China
| | - C Y Du
- Department of Hepatobiliary Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China
| | - J Luo
- Department of Hepatobiliary and Intestinal Surgery, Hunan Cancer Hospital, Changsha 410031, China
| | - J F Liu
- Department of Hepatobiliary and Pancreatic Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China
| | - T Q Liu
- Department of General Surgery, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China
| | - Q Liu
- Department of Hepatobiliary Surgery, Liuzhou People's Hospital, Liuzhou 545006, China
| | - J Liu
- Department of Hepatobiliary Surgery, Guizhou Provicial People's Hospital, Guiyang 550002, China
| | - X H Li
- Department of Hepatobiliary Surgery, Liaocheng People's Hospital, Liaocheng 252000, China
| | - L C Wang
- Department of General Surgery, the Third People's Hospital of Hainan Province, Sanya 572000, China
| | - Z P Fang
- Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Linhai 317099, China
| | - W M Yi
- Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital, Changsha 410005, China
| | - Y J Chen
- Department of Hepatobiliary Surgery, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou 510120, China
| | - Q L Li
- Department of Hepatobiliary and Pancreatic Surgery, the Second Xiangya Hospital of Central South University, Changsha 410011, China
| | - Y Ni
- Department of Hepatobiliary and Pancreatic Surgery, Shenzhen Second People's Hospital, Shenzhen 518035, China
| | - J C Wu
- Department of Hepatobiliary Surgery, Hainan Provincial People's Hospital, Haikou 570311, China
| | - C J Qin
- Department of General Surgery, Huaihe Hospital of Henan University, Kaifeng 475000, China
| | - Y L Gu
- Department of Hepatobiliary Surgery, Affiliated Hospital of Jiangnan Univeisity, Wuxi 214122, China
| | - Z Lu
- Department of Hepatobiliary Surgery, the First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China
| | - Z J Lun
- Department of Hepatobiliary Vascular Surgery, Zaozhuang Municipal Hospital, Zaozhuang 277101, China
| | - L X Du
- Department of Hepatobiliary Surgery, Shanxi Provincial People's Hospital, Xi'an 710068, China
| | - G Chen
- Department of Hepatobiliary and Pancreatic Surgery, the First People's Hospital of Kunming, Kunming 650034, China
| | - Q C Zheng
- Department of Hepatobiliary Surgery, Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430022, China
| | - K J Sun
- Department of Hepatobiliary Surgery, Zibo Central Hospital, Zibo 255036, China
| | - W Q Han
- Department of Urinary Surgery, Hunan Cancer Hospital, Changsha 410031, China
| | - J Yu
- Department of Hepatobiliary and Pancreatic Surgery, the First Hospital of Zhejiang University School of Medicine, Hangzhou 310003, China
| |
Collapse
|
5
|
Zhang ZK, Wang YJ, Liu JF. [Arrested pneumatization of the sphenoid sinus: imaging characteristics]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2023; 58:986-991. [PMID: 37767655 DOI: 10.3760/cma.j.cn115330-20230301-00095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 09/29/2023]
Abstract
Objective: To explore and analyze the imaging features of arrested pneumatization of the sphenoid sinus, so as to provide reference for identifying sphenoid lesions. Methods: From May 2018 to September 2019, a retrospective analysis was conducted on 350 patients (183 males and 167 females, aged between 18 and 73 years) who had been completed the sinus CT examination in the outpatient department of Beijing Chaoyang Hospital Affiliated to Capital Medical University. Their imaging data were collected and the CT/MRI characteristics of the sphenoid body were observed. SPSS 26.0 software was used for statistical analysis. Results: The rate of arrested pneumatization of the sphenoid sinus was 2.0% (7/350), which occurred in the pteroid process, the slope region, and the sphenoid sinus body, respectively. CT showed a nondilated mixed-density lesion (7/7) in the pneumatizable sphenoid body. Within these regions, both fat and soft tissue density (7/7) were present. Internal curve calcification was observed in part of the region (3/7). The skull base canal structure was not affected (7/7). MRI showed a clear non-dilated lesion with an adipose signal, and none of the lesions showed medulla dilation or cortical destruction. Conclusions: Arrested pneumatization of the sphenoid sinus is a normal anatomic variation. When non-dilated lesions with clear bony boundaries and internal fatty components are encountered in the vaporizable region of the sphenoid sinus, the possibility of arrested pneumatization of the sphenoid sinus should be considered.
Collapse
Affiliation(s)
- Z K Zhang
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - Y J Wang
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - J F Liu
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| |
Collapse
|
6
|
Zhang RQ, Li YF, Wang YB, Zhao JH, Liu JF. [Clinical study on dysosmia associated with SARS-CoV-2 infection]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2023; 58:1038-1044. [PMID: 37840173 DOI: 10.3760/cma.j.cn115330-20230117-00030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 10/17/2023]
Affiliation(s)
- R Q Zhang
- Beijing University of Chinese Medicine, Beijing 100029, China Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - Y F Li
- Beijing University of Chinese Medicine, Beijing 100029, China Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - Y B Wang
- Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - J H Zhao
- Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - J F Liu
- Beijing University of Chinese Medicine, Beijing 100029, China Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| |
Collapse
|
7
|
Li YF, Zhang RQ, Wang YB, Zhao JH, Liu JF. [Research status in COVID-19-related taste dysfunction]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2023; 58:817-822. [PMID: 37599248 DOI: 10.3760/cma.j.cn115330-20230106-00008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 08/22/2023]
Affiliation(s)
- Y F Li
- Beijing University of Chinese Medicine, Beijing 100029, China Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - R Q Zhang
- Beijing University of Chinese Medicine, Beijing 100029, China Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - Y B Wang
- Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - J H Zhao
- Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - J F Liu
- Beijing University of Chinese Medicine, Beijing 100029, China Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| |
Collapse
|
8
|
Liu MF, Ma RX, Cao XB, Zhang H, Zhou SH, Jiang WH, Jiang Y, Sun JW, Yang QT, Li XZ, Sun YN, Shi L, Wang M, Song XC, Chen FQ, Zhang XS, Wei HQ, Yu SQ, Zhu DD, Ba L, Cao ZW, Xiao XP, Wei X, Lin ZH, Chen FH, Shan CG, Wang GK, Ye J, Qu SH, Zhao CQ, Wang ZL, Li HB, Liu F, Cui XB, Ye SN, Liu Z, Xu Y, Cai X, Hang W, Zhang RX, Zhao YL, Yu GD, Shi GG, Lu MP, Shen Y, Zhao YT, Pei JH, Xie SB, Yu LG, Liu YH, Gu SS, Yang YC, Cheng L, Liu JF. [Incidence and prognosis of olfactory and gustatory dysfunctions related to infection of SARS-CoV-2 Omicron strain: a national multi-center survey of 35 566 population]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2023; 58:579-588. [PMID: 37339898 DOI: 10.3760/cma.j.cn115330-20230316-00117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 06/22/2023]
Abstract
Objective: This cross-sectional investigation aimed to determine the incidence, clinical characteristics, prognosis, and related risk factors of olfactory and gustatory dysfunctions related to infection with the SARS-CoV-2 Omicron strain in mainland China. Methods: Data of patients with SARS-CoV-2 from December 28, 2022, to February 21, 2023, were collected through online and offline questionnaires from 45 tertiary hospitals and one center for disease control and prevention in mainland China. The questionnaire included demographic information, previous health history, smoking and alcohol drinking, SARS-CoV-2 vaccination, olfactory and gustatory function before and after infection, other symptoms after infection, as well as the duration and improvement of olfactory and gustatory dysfunction. The self-reported olfactory and gustatory functions of patients were evaluated using the Olfactory VAS scale and Gustatory VAS scale. Results: A total of 35 566 valid questionnaires were obtained, revealing a high incidence of olfactory and taste dysfunctions related to infection with the SARS-CoV-2 Omicron strain (67.75%). Females(χ2=367.013, P<0.001) and young people(χ2=120.210, P<0.001) were more likely to develop these dysfunctions. Gender(OR=1.564, 95%CI: 1.487-1.645), SARS-CoV-2 vaccination status (OR=1.334, 95%CI: 1.164-1.530), oral health status (OR=0.881, 95%CI: 0.839-0.926), smoking history (OR=1.152, 95%CI=1.080-1.229), and drinking history (OR=0.854, 95%CI: 0.785-0.928) were correlated with the occurrence of olfactory and taste dysfunctions related to SARS-CoV-2(above P<0.001). 44.62% (4 391/9 840) of the patients who had not recovered their sense of smell and taste also suffered from nasal congestion, runny nose, and 32.62% (3 210/9 840) suffered from dry mouth and sore throat. The improvement of olfactory and taste functions was correlated with the persistence of accompanying symptoms(χ2=10.873, P=0.001). The average score of olfactory and taste VAS scale was 8.41 and 8.51 respectively before SARS-CoV-2 infection, but decreased to3.69 and 4.29 respectively after SARS-CoV-2 infection, and recovered to 5.83and 6.55 respectively at the time of the survey. The median duration of olfactory and gustatory dysfunctions was 15 days and 12 days, respectively, with 0.5% (121/24 096) of patients experiencing these dysfunctions for more than 28 days. The overall self-reported improvement rate of smell and taste dysfunctions was 59.16% (14 256/24 096). Gender(OR=0.893, 95%CI: 0.839-0.951), SARS-CoV-2 vaccination status (OR=1.334, 95%CI: 1.164-1.530), history of head and facial trauma(OR=1.180, 95%CI: 1.036-1.344, P=0.013), nose (OR=1.104, 95%CI: 1.042-1.171, P=0.001) and oral (OR=1.162, 95%CI: 1.096-1.233) health status, smoking history(OR=0.765, 95%CI: 0.709-0.825), and the persistence of accompanying symptoms (OR=0.359, 95%CI: 0.332-0.388) were correlated with the recovery of olfactory and taste dysfunctions related to SARS-CoV-2 (above P<0.001 except for the indicated values). Conclusion: The incidence of olfactory and taste dysfunctions related to infection with the SARS-CoV-2 Omicron strain is high in mainland China, with females and young people more likely to develop these dysfunctions. Active and effective intervention measures may be required for cases that persist for a long time. The recovery of olfactory and taste functions is influenced by several factors, including gender, SARS-CoV-2 vaccination status, history of head and facial trauma, nasal and oral health status, smoking history, and persistence of accompanying symptoms.
Collapse
Affiliation(s)
- M F Liu
- Graduate School of Beijing University of Chinese Medicine, Beijing 100029, China Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - R X Ma
- Department of Otorhinolaryngology Head and Neck Surgery, the First People's Hospital of Yinchuan, Yinchuan 750001, China
| | - X B Cao
- Department of Otorhinolaryngology, the First People's Hospital of Yunnan Province, Kunming 650100, China
| | - H Zhang
- Department of Otorhinolaryngology Head and Neck Surgery, the First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
| | - S H Zhou
- Department of Otorhinolaryngology Head and Neck Surgery, the First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310003, China
| | - W H Jiang
- Department of Otorhinolaryngology Head and Neck Surgery, Xiangya Hospital Central South University, Changsha 410008, China
| | - Y Jiang
- Department of Otorhinolaryngology Head and Neck Surgery, the Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - J W Sun
- Department of Otorhinolaryngology Head and Neck Surgery, the First Affiliated Hospital of USTC, Hefei 230001, China
| | - Q T Yang
- Department of Otorhinolaryngology Head and Neck Surgery, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
| | - X Z Li
- Department of Otorhinolaryngology Head and Neck Surgery, Qilu Hospital of Shandong University, Jinan 250012, China
| | - Y N Sun
- Department of Otorhinolaryngology Head and Neck Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin 150001, China
| | - L Shi
- Department of Rhinology and Allergy, Shandong Provincial ENT Hospital, Shandong University, Jinan 250299, China
| | - M Wang
- Department of Otorhinolaryngology Head and Neck Surgery, Peking University People's Hospital, Beijing 100032, China
| | - X C Song
- Department of Otorhinolaryngology Head and Neck Surgery, Yantai Yuhuangding Hospital, Qingdao University, Yantai 264000, China
| | - F Q Chen
- Department of Otorhinolaryngology Head and Neck Surgery, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, China
| | - X S Zhang
- Gansu Provincial Center for Disease Control and Prevention, Lanzhou 730000, China
| | - H Q Wei
- Department of Otorhinolaryngology Head and Neck Surgery, the First Affiliated Hospital of China Medical University, Shenyang 110001, China
| | - S Q Yu
- Department of Otorhinolaryngology Head and Neck Surgery, Tongji Hospital, Tongji Medical University, Shanghai 200065, China
| | - D D Zhu
- Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Union Hospital of Jilin University, Changchun 130033, China
| | - L Ba
- Department of Otorhinolaryngology Head and Neck Surgery, Xizang Autonomous Region People's Hospital, Lasa 850000, China
| | - Z W Cao
- Department of Otorhinolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, China
| | - X P Xiao
- Department of Otorhinolaryngology Head and Neck Surgery, Hunan Provincial People's Hospital, Changsha 410005, China
| | - X Wei
- Department of Otorhinolaryngology Head and Neck Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou 570311, China
| | - Z H Lin
- Department of Otorhinolaryngology Head and Neck Surgery, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, China
| | - F H Chen
- Department of Otorhinolaryngology Head and Neck Surgery, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
| | - C G Shan
- Department of Otorhinolaryngology Head and Neck Surgery, the Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
| | - G K Wang
- Department of Otorhinolaryngology Head and Neck Surgery, Henan Provincial People's Hospital, Zhengzhou 450003, China
| | - J Ye
- Department of Otorhinolaryngology Head and Neck Surgery, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - S H Qu
- Department of Otorhinolaryngology Head and Neck Surgery, Guangxi Zhuang Autonomous Region People's Hospital, Nanning 530021, China
| | - C Q Zhao
- Department of Otorhinolaryngology Head and Neck Surgery, Shanxi Medical University Affiliated Second Hospital, Taiyuan 030001, China
| | - Z L Wang
- Department of Otorhinolaryngology Head and Neck Surgery, XuanWu Hospital, Capital Medical University, Beijing 100053, China
| | - H B Li
- Department of Otorhinolaryngology Head and Neck Surgery, Eye, Ear, Nose and Throat Hospital, Shanghai Medical College, Fudan University, Shanghai 200031, China
| | - F Liu
- Department of Otorhinolaryngology Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
| | - X B Cui
- Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010059, China
| | - S N Ye
- Department of Otorhinolaryngology Head and Neck Surgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China
| | - Z Liu
- Department of Otorhinolaryngology Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - Y Xu
- Department of Otorhinolaryngology Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China
| | - X Cai
- Department of Otorhinolaryngology Head and Neck Surgery, Qinghai Provincial People's Hospital, Xining 810000, China
| | - W Hang
- Department of Otorhinolaryngology Head and Neck Surgery, Tianjin Huanhu Hospital, Tianjin 300350, China
| | - R X Zhang
- Department of Otorhinolaryngology Head and Neck Surgery, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China
| | - Y L Zhao
- Department of Otorhinolaryngology Head and Neck Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| | - G D Yu
- Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China
| | - G G Shi
- Department of Otorhinolaryngology Head and Neck Surgery, Shandong Provincial Hospital, Affiliated to Shandong First Medical University, Jinan 250021, China
| | - M P Lu
- Department of Otorhinolaryngology, the First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
| | - Y Shen
- Department of Otorhinolaryngology Head and Neck Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
| | - Y T Zhao
- Department of Otorhinolaryngology Head and Neck Surgery, the First People's Hospital of Yinchuan, Yinchuan 750001, China
| | - J H Pei
- Department of Otorhinolaryngology, the First People's Hospital of Yunnan Province, Kunming 650100, China
| | - S B Xie
- Department of Otorhinolaryngology Head and Neck Surgery, Xiangya Hospital Central South University, Changsha 410008, China
| | - L G Yu
- Department of Otorhinolaryngology Head and Neck Surgery, the Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - Y H Liu
- Department of Otorhinolaryngology Head and Neck Surgery, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
| | - S S Gu
- Department of Otorhinolaryngology Head and Neck Surgery, Qilu Hospital of Shandong University, Jinan 250012, China
| | - Y C Yang
- Department of Otorhinolaryngology Head and Neck Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
| | - L Cheng
- Department of Otorhinolaryngology, the First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
| | - J F Liu
- Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| |
Collapse
|
9
|
Zhang Y, Liu JF, Guo M. [Progress on diagnosis and treatment of nasal valve dysfunction]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2023; 58:380-384. [PMID: 37005775 DOI: 10.3760/cma.j.cn115330-20221122-00701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 04/04/2023]
Affiliation(s)
- Y Zhang
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - J F Liu
- Department of Otorhinolaryngology, China-Japan Friendship Hospital, Beijing 100029, China
| | - M Guo
- Department of Orthopedic, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| |
Collapse
|
10
|
Liu JF. [Role of surgery in the treatment of nasopharyngeal carcinoma]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2022; 57:1347-1353. [PMID: 36404664 DOI: 10.3760/cma.j.cn115330-20220614-00350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Affiliation(s)
- J F Liu
- Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| |
Collapse
|
11
|
Han HL, Lyu QP, Liu JF, Zhao JH. [Evaluation of reliability and validity of the Chinese version of a new symptom score of laryngopharyngeal reflux disease]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2022; 57:1185-1190. [PMID: 36319123 DOI: 10.3760/cma.j.cn115330-20220531-00322] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
Objective: To produce the Chinese version of a new reflux symptom score (RSS) of laryngopharyngeal reflux disease (LPRD) and to evaluate its reliability, validity and clinical value. Methods: This was a retrospective study which contained 42 healthy volunteers and 135 possible LPRD patients. RSI,RFS,oropharyngeal pH monitoring (Dx-pH monitoring) and RSS of each patient were performed. RSS was performed again after 1 week. Confirmed LPRD patients were treated with proton pump inhibitor for 8 week. And RSS was performed again after treatment. Reliability and validity of RSS were evaluated. Results: The Cronbach's α coefficient of RSS was 0.77, which indicated good internal reliability of the new score. The results of test-retest found all P values were less than 0.05, which supported good external reliability. Comparing RSS with laryngopharyngeal reflux test results, the diagnostic coincidence rate was 84.44% (114/135), and the positive predictive value was 85.71% (114/133), which showed good criterion validity. After 8 weeks treatment of PPI, RSS decreased significantly (pretreatment 84.79±42.50,posttreatment 20.11±22.82,t=-10.54, P<0.001), indicating good reactivity of RSS. The score of quality of life impact (Qol) in possible LPRD patients was obviously higher than that of healthy volunteers (t=7.15,P<0.001). All patients and volunteers believed that RSS was a good way to evaluate their symptoms. Conclusions: The new score RSS have good internal and external reliability, criterion validity and reactivity. RSS can be one of the important reference indexes to evaluate LPRD.
Collapse
Affiliation(s)
- H L Han
- Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - Q P Lyu
- Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - J F Liu
- Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - J H Zhao
- Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| |
Collapse
|
12
|
Wang J, Yan TT, Feng YL, He YL, Yang Y, Liu JF, Yao NJ, Zhu YG, Zhao YR, Chen TY. [The effect of maternal HBV DNA levels on HBV intrauterine transmission and fetal distress]. Zhonghua Gan Zang Bing Za Zhi 2022; 30:873-878. [PMID: 36207944 DOI: 10.3760/cma.j.cn501113-20190610-00207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
Aim: To identify the key risk factors of intrauterine hepatitis B virus transmission (HBV) and its effect on the placenta and fetus. Methods: 425 infants born to hepatitis B surface antigen (HBsAg)-positive pregnant women who received combined immunization with hepatitis B immunoglobulin and hepatitis B vaccine between 2009 to 2015 were prospectively enrolled in this study. The intrauterine transmission situation was assessed by dynamic monitoring of infants HBV DNA load and quantitative HBsAg. Univariate and multivariate regression analysis was used to determine the high risk factors for intrauterine transmission. Stratified analysis was used to determine the relationship between maternal HBV DNA load and fetal distress. Transmission electron microscopy was used to observe HBV Effects on placental tissue. Results: HBV intrauterine infection rate was 2.6% (11/425). Multivariate analysis result showed that the maternal HBV DNA load was an independent risk factor for intrauterine infection among infants (P=0.011). Intrauterine infection and distress rate was significantly higher in infants with with maternal HBV DNA>106 IU/ml than those with HBV DNA <106 IU/ml (12.2% vs. 1.8%; χ2=11.275, P=0.006), and (24.4% vs. 16.0%, χ2=3.993, P=0.046). Transmission electron microscopy showed that mitochondrial edema, endoplasmic reticulum expansion and thicker basement membrane were apparent when the maternal HBV DNA>106 IU/ml than that of maternal HBV DNA<106 IU/ml (960 nm vs. 214 nm, Z=-2.782, P=0.005) in the placental tissue. Conclusion: Maternal HBV DNA>106 IU/ml is associated not only with intrauterine infection, but also with increased incidence of intrauterine distress and placental sub-microstructural changes, providing strong clinical and histological evidence for pregnancy avoidance and treatment in this population.
Collapse
Affiliation(s)
- J Wang
- The Department of Rheumatology, First Affiliated Hospital of Medicine College, Xi'an Jiaotong University, Xi'an 710061,China
| | - T T Yan
- The Department of Infectious Disease, First Affiliated Hospital of Medicine College, Xi'an Jiaotong University, Xi'an 710061,China
| | - Y L Feng
- The Department of Infectious Disease, First Affiliated Hospital of Medicine College, Xi'an Jiaotong University, Xi'an 710061,China
| | - Y L He
- The Department of Infectious Disease, First Affiliated Hospital of Medicine College, Xi'an Jiaotong University, Xi'an 710061,China
| | - Y Yang
- The Department of Infectious Disease, First Affiliated Hospital of Medicine College, Xi'an Jiaotong University, Xi'an 710061,China
| | - J F Liu
- The Department of Infectious Disease, First Affiliated Hospital of Medicine College, Xi'an Jiaotong University, Xi'an 710061,China
| | - N J Yao
- The Department of Infectious Disease, First Affiliated Hospital of Medicine College, Xi'an Jiaotong University, Xi'an 710061,China
| | - Y G Zhu
- The Department of Infectious Disease, First Affiliated Hospital of Medicine College, Xi'an Jiaotong University, Xi'an 710061,China
| | - Y R Zhao
- The Department of Infectious Disease, First Affiliated Hospital of Medicine College, Xi'an Jiaotong University, Xi'an 710061,China
| | - T Y Chen
- The Department of Infectious Disease, First Affiliated Hospital of Medicine College, Xi'an Jiaotong University, Xi'an 710061,China
| |
Collapse
|
13
|
Zhou L, Chen X, Wang J, Liu ZY, You J, Lan S, Liu JF. [Predictive value of mismatch negativity and P3a combined with electroencephalogram reactivity for the prognosis of comatose patients after severe brain injury]. Zhonghua Yi Xue Za Zhi 2022; 102:2265-2271. [PMID: 35927057 DOI: 10.3760/cma.j.cn112137-20220413-00799] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Objective: To explore the clinical value of mismatch negativity and P3a combined with electroencephalogram (EEG) reactivity to predict the prognosis of patients after severe brain injury. Methods: The clinical data of patients with severe brain injury who were admitted to the neurosurgical intensive care unit of Xiangya Hospital of Central South University from October 2019 to July 2020 were retrospectively analyzed. All patients underwent evaluation of auditory mismatch negativity (MMN), P3a, and EEG reactivity (EEG-R) within 28 days after the onset of coma. Patients were divided into two groups using the 3-month Glasgow Outcome Scale (GOS) after coma onset, a GOS score of 3-5 was defined as a favorable outcome, and GOS grades 1-2 were defined as an unfavorable outcome. The correlation between clinical indicators and prognosis was analyzed, and the predictive values of statistically significant indicators and the cut-off values were determined using the receiver operating characteristic (ROC) curve. Results: A total of 48 patients were enrolled in the study, including 35 males and 13 females (age range:18-68 years old). Twenty-nine of the patients had a favorable outcome and 19 had an unfavorable outcome. The Glasgow Coma Scale (GCS), EEG-R, absolute amplitude of MMN at Fz (FzMMNA), and amplitude of P3a at Cz (CzP3aA) were significantly correlated with the prognosis of comatose patients (P<0.001). Multivariate logistic regression analysis revealed that only EEG-R, FzMMNA, and CzP3aA were independent predictors for the prognosis of comatose patients after severe brain injury (all P<0.05), with the area under the curve (AUC) of 0.757 (0.613-0.900), 0.912 (0.830-0.994) and 0.887 (0.793-0.981), respectively. The combination of FzMMNA and CzP3aA and the combinationof EEG-R, FzMMNA and CzP3aA increased the value of AUC to 0.942 (0.879-1.000) and 0.964 (0.920-1.000), respectively. Moreover, a cut-off value of 1.27 μV and 2.64 μV for FzMMNA and CzP3aA, respectively, yielded the best sensitivity and specificity for the prognosis prediction of patients with severe brain injury [FzMMNA: 89.66%(26/29) and 84.21%(16/19); CzP3aA:82.76%(24/29) and 84.21%(16/19)]. Conclusion: This study indicates that the combination of EEG-R, FzMMNA, and CzP3aA may serve as a favorable prognostic indicator for comatose patients after severe brain injury.
Collapse
Affiliation(s)
- L Zhou
- Department of Neurosurgery, Xiangya Hospital Central South University, Changsha 410008, China
| | - X Chen
- Department of Neurosurgery, Xiangya Hospital Central South University, Changsha 410008, China
| | - J Wang
- Department of Neurosurgery, Xiangya Hospital Central South University, Changsha 410008, China
| | - Z Y Liu
- Department of Neurosurgery, Xiangya Hospital Central South University, Changsha 410008, China
| | - J You
- Department of Neurosurgery, Xiangya Hospital Central South University, Changsha 410008, China
| | - S Lan
- Department of Neurosurgery, Xiangya Hospital Central South University, Changsha 410008, China
| | - J F Liu
- Department of Neurosurgery, Xiangya Hospital Central South University, Changsha 410008, China
| |
Collapse
|
14
|
Yuan HS, Liu JF. [Pay attention to the imaging research in marathon-related musculoskeletal injuries]. Zhonghua Yi Xue Za Zhi 2022; 102:611-614. [PMID: 35249304 DOI: 10.3760/cma.j.cn112137-20220106-00036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Marathon-related musculoskeletal injuries are very common. The imaging research of musculoskeletal injuries may provide scientific support for the health protection of marathon athletes. Unfortunately, imaging studies on musculoskeletal system injury are relatively lacking, large sample studies are almost blank, and neither imaging methods nor study populations are comprehensive enough. The imaging study of marathon-related musculoskeletal injuries remains to be further studied. As a country with a large number of marathon participants, China should strengthen relevant imaging studies to provide more health protection for marathon enthusiasts and professional athletes.
Collapse
Affiliation(s)
- H S Yuan
- Department of Radiology, the Third Hospital of Peking University, Beijing 100091, China
| | - J F Liu
- Department of Radiology, the Third Hospital of Peking University, Beijing 100091, China
| |
Collapse
|
15
|
Zhao JH, Liu JF, Han DZ, Yang Y, Zhao YB, Wang FJ, You F. [Endoscopic posterior nasal neurectomy for the treatment of allergic rhinitis: anatomy and analysis of clinical efficacy]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2022; 57:295-300. [PMID: 35325941 DOI: 10.3760/cma.j.cn115330-20210710-00447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Objective: To propose total posterior nasal neurectomy with transection of sphenopalatine neurovascular bundle from anatomy for the treatment of allergic rhinitis, and to explore its clinical application. Methods: Two fresh cadaveric heads (4 sides) were dissected through endoscopic transnasal middle meatus approach at Otorhinolaryngology Anatomy Laboratory of China-Japan Friendship Hospital. The structures of the craniofacial bone related to the surgical approach were observed. Twelve patients with allergic rhinitis who treated in Department of Otorhinolaryngology, China-Japan Friendship Hospital from Feb. 1 2019 to Jun. 10 2021 were selected. All the patients were treated by posterior nasal neurotomy with the technique of complete transection of sphenopalatine neurovascular bundle and followed up for 1 year after sugery. During the follow-up, 2 patients were lost. The other 10 patients included 4 males and 6 females, aging from 29 to 69 years. Visual Analogue Scale (VAS) and Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) were used to evaluate the effect of the surgery. SPSS 25.0 software was used for statistical analysis. Results: Important anatomic landmarks of transnasal middle meatus approach were obtained during anatomy, such as ethmoid crest, sphenopalatine foramen/notch, palatine orbital process and sphenopalatine process. The postoperative VAS scores of nose, eye, pharynx, ear and whole body and total VAS scores were significantly lower than those before operation, with statistically significant difference (nose 2.50±1.70 vs 6.47±2.17, eyes 1.15±0.89 vs 3.60±2.57, pharynx 1.30±1.36 vs 4.25±3.64, ear 1.10±1.03 vs 2.67±2.00, whole body 1.08±1.24 vs 3.60±1.17, total 7.13±4.31 vs 20.58±9.05, all P<0.05). The postoperative RQLQ scores of sleep, nose, eyes, practical problems, emotion, activity and the total RQLQ scores of patients were significantly lower than those before operation, with statistically significant difference (sleep 0.80±0.69 vs 2.93±1.33, nose 1.38±1.18 vs 3.93±1.50, eyes 0.58±0.66 vs 1.80±1.25, practical problems 1.10±1.22 vs 3.03±1.84, emotion 1.00±1.81 vs 2.58±2.00, activity 2.77±2.93 vs 6.00±1.85, total 8.99±8.92 vs 22.42±8.69, all P<0.05). There was no significant difference in preoperative and postoperative scores of non-nasal/ocular symptoms (1.37±1.60 vs 2.16±1.12, P=0.166). There was no other complication except 2 cases with short-term postoperative numbness. Conclusions: Total posterior nasal neurectomy with transection of sphenopalatine neurovascular bundle is a safe, effective and feasible method for the treatment of intractable allergic rhinitis, and its long-term efficacy needs further observation.
Collapse
Affiliation(s)
- J H Zhao
- Department of Otorhinolaryngology, China-Japan Friendship Hospital, Beijing 100029, China
| | - J F Liu
- Department of Otorhinolaryngology, China-Japan Friendship Hospital, Beijing 100029, China China Japan Friendship Clinical College, Beijing University of Traditional Chinese Medicine, Beijing 100029, China
| | - D Z Han
- Department of Otorhinolaryngology, China-Japan Friendship Hospital, Beijing 100029, China China Japan Friendship Clinical College, Beijing University of Traditional Chinese Medicine, Beijing 100029, China
| | - Y Yang
- Department of Otorhinolaryngology, China-Japan Friendship Hospital, Beijing 100029, China
| | - Y B Zhao
- Department of Otorhinolaryngology, China-Japan Friendship Hospital, Beijing 100029, China
| | - F J Wang
- Department of Otorhinolaryngology, China-Japan Friendship Hospital, Beijing 100029, China
| | - Fangjia You
- China Japan Friendship Clinical College, Beijing University of Traditional Chinese Medicine, Beijing 100029, China
| |
Collapse
|
16
|
Che XY, Liu JF. [Assessment of folate status among women of childbearing age from 2000 to 2020]. Zhonghua Yu Fang Yi Xue Za Zhi 2022; 56:377-385. [PMID: 35381663 DOI: 10.3760/cma.j.cn112150-20211215-01161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Objective: To analyze the folate status among women of childbearing age worldwide from 2000 to 2020, and explore the impact of socioeconomic factors on folate status, so as to provide support for the formulation of relevant supplementary policies in China in the future. Methods: The "folate" "folic acid" "deficiency" "status" "women" "childbearing" and "reproductive" were used as Chinese and English keywords to systematically search CNKI and PubMed database. Global Health Data Exchange database (GDHx), Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia datasets (BRINDA) and Ground Work publications were systematically searched with "micronutrients" and "nutrition" as keywords. The retrieval time was from January 1, 2000 to August 31, 2020, and the language was restricted to English and Chinese. After title, abstract and full-text screening, a total of 45 literatures were included. The folate status of women of childbearing age in the eligible literature was analyzed, and the income and folate status were tested by Kruskal Wallis H test and Nemenyi test. Results: The M (Q1, Q3) of serum folate deficiency rate and erythrocyte folate insufficiency rate in women of childbearing age were 15.0% (3.5%, 37.0%) and 49.0% (22.0%, 83.0%). There were great differences in serum folate status and serum folate deficiency rate among women of childbearing age in different income countries. The serum folate deficiency rate of women of childbearing age in low-income countries was significantly higher than that in middle and high-income countries. Conclusion: The folate status of women of childbearing age in most countries has not reached the ideal state from 2000 to 2020. More studies on folate supplementation programs should be carried out.
Collapse
Affiliation(s)
- X Y Che
- Institute of Reproductive and Child Health, Peking University/Key Laboratory of Reproductive Health, National Health Commission of the People's Republic of China,Beijing 100191, China Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - J F Liu
- Institute of Reproductive and Child Health, Peking University/Key Laboratory of Reproductive Health, National Health Commission of the People's Republic of China,Beijing 100191, China Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| |
Collapse
|
17
|
Guo ZY, Liu JF, Zhou CH, Qian MB, Chen YD, Zhou XN, Li SZ. [Current status and challenges for taeniasis and cysticercosis control in China]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2021; 33:563-569. [PMID: 35128885 DOI: 10.16250/j.32.1374.2021170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
In the WHO new road map for neglected tropical diseases 2021-2030, the disease-specific targets are classified into control, elimination as a public health problem, elimination and eradication, and taeniasis and cysticercosis are targeted for control. The overall prevalence of taeniasis and cysticercosis is low in China, and varies remarkably in regions and populations; however, there are many challenges for elimination of taeniasis and cysticercosis in China. Based on previous taeniasis and cysticercosis control programs, developing a sensitive taeniasis and cysticercosis surveillance-response system, updating criteria for diagnosis of taeniasis and cysticercosis, proposing a national guideline for treatment of taeniasis and cysticercosis, and strengthening interdisciplinary and intersectoral communications and collaborations are urgently needed under the One Health concept.
Collapse
Affiliation(s)
- Z Y Guo
- National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, National Research Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Center for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai 200025, China
| | - J F Liu
- National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, National Research Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Center for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai 200025, China
| | - C H Zhou
- National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, National Research Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Center for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai 200025, China
| | - M B Qian
- National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, National Research Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Center for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai 200025, China
- School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
| | - Y D Chen
- National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, National Research Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Center for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai 200025, China
| | - X N Zhou
- National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, National Research Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Center for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai 200025, China
- School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
| | - S Z Li
- National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, National Research Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Center for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai 200025, China
- School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
| |
Collapse
|
18
|
Wang YJ, Ren YY, Tang CY, Li XT, Liu JF. [Clinical characteristics analysis of two cases of nosebleed with acute cerebral hemorrhage]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2021; 56:1336-1337. [PMID: 34963223 DOI: 10.3760/cma.j.cn115330-20210304-00108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Affiliation(s)
- Y J Wang
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - Y Y Ren
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - C Y Tang
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - X T Li
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - J F Liu
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| |
Collapse
|
19
|
Zhou M, Liu JF, Yuan JJ, Yan ZF, Dai JS, Ge XY, Wang NY. [The research progress of excitatory and inhibitory inputs of lateral superior olive]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2021; 56:1008-1012. [PMID: 34666458 DOI: 10.3760/cma.j.cn115330-20210825-00571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- M Zhou
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China
| | - J F Liu
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China
| | - J J Yuan
- Department of Otorhinolaryngology Head and Neck Surgery, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100020, China
| | - Z F Yan
- Department of Otorhinolaryngology Head and Neck Surgery, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100020, China
| | - J S Dai
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China
| | - X Y Ge
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China
| | - N Y Wang
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China
| |
Collapse
|
20
|
Liu JF, Brigitta XL, Wang YJ, Dai JS, Ren YY, Zhang Y, Li W, Wang NY. [Clinical characteristics of patients with odontogenic sinusitis underwent endoscopic sinus surgery]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2021; 56:848-853. [PMID: 34521170 DOI: 10.3760/cma.j.cn115330-20201217-00928] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To analyze the clinical features of patients with odontogenic sinusitis (OS) treated by endoscopic sinus surgery (ESS). Methods: A retrospective investigation was carried out in our 27 (16 males and 11 females) cases with OS aged (49.74±14.42) years old. Subjects were hospitalized between January 2018 and November 2020 from Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital. The medical history, symptoms, result of nasal endoscopy and paranasal sinus computed tomography (CT) were analyzed statistically by SPSS 19.0. Results: OS mainly occured on unilateral sinuses, with a duration of (8.56±11.79) months. Seventy point four percent (19/27) of the patients had a course within six-month, only 11% was over 12 months (3/27). Symptoms mostly showed as nasal obstruction (88.9%; 24/27), runny nose (81.5%; 22/27), nasal stinks (16/19) and postnasal drip (10/10). Sixty-three percent (17/27) of the OS patients had a dental history. Nasal endoscopic examination revealed a swelling of the ostiomeatal complex (77.8%; 21/27), medial wall interhal displacement of maxillary sinus (55.6%; 15/27), white emulsion-like purulent secretion in the middle meatus (70.4%; 19/27) and nasal polyps (59.3%; 16/27). Etiology of OS included implant-related problems (14.8%; 4/27) and periodontal disease (85.2%; 23/27). Conclusions: OS is usually unilateral sinusitis with a short history. Its clinical features show nasal stinks, white emulsion-like purulent secretion in the middle meatus and imaging findings of unilateral maxillary sinusitis with tooth-related lesions.
Collapse
Affiliation(s)
- J F Liu
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - X L Brigitta
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - Y J Wang
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - J S Dai
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - Y Y Ren
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - Y Zhang
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - W Li
- Department of Oral and Maxillofacial Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - N Y Wang
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| |
Collapse
|
21
|
Wang YX, Li FL, Du LX, Liu JF, Huo LG, Li SQ, Tian B. The Co-Expression of Melanoma-Antigen Family a Proteins and New York Esophageal Squamous Cell Carcinoma-1 in Breast Cancer: A Pilot Study. Cancer Manag Res 2021; 13:6123-6128. [PMID: 34377031 PMCID: PMC8349529 DOI: 10.2147/cmar.s316759] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2021] [Accepted: 07/13/2021] [Indexed: 11/23/2022] Open
Abstract
Objective The aim of this study was to quantify the expression of melanoma-antigen family A proteins (MAGE-A) and New York esophageal squamous cell carcinoma-1 (NY-ESO-1) in breast cancer and establish the prognosis of breast cancer patients with MAGE-A and NY-ESO-1 co-expression. Methods A total of 122 patients with breast cancer were recruited for this study. Their clinicopathological data were collected retrospectively, and the MAGE-A and NY-ESO-1 expressions in paraffin-embedded specimens from the 122 patients were evaluated using immunohistochemical analysis. In addition, the survival states of the patients were recorded. Results Fifty-four patients (44.26%) were MAGE-A positive and 46 (37.70%) were NY-ESO-1 positive. Interestingly, 22 of the 46 NY-ESO-1-positive cases co-expressed MAGE-A. The expression of MAGE-A was positively associated with estrogen-receptor status (χ2 = 4.026, p = 0.045) and human epidermal growth factor receptor 2 status (χ2 = 5.482, p = 0.019), while the expression of NY-ESO-1 was positively associated with p53 expression (χ2 = 4.541, p = 0.033). Of the 122 patients, the lowest survival rate was observed in patients with NY-ESO-1 (+)/MAGE-A (+), with a 5-year survival rate of 59.09% and a median survival of 97 months. Conclusion The results showed that MAGE-A and NY-ESO-1 were frequently expressed in breast cancer patients. The co-expression of MAGE-A and NY-ESO-1 occurred in about 18% of these patients, and it may indicate a poor prognosis.
Collapse
Affiliation(s)
- Yu-Xin Wang
- Department of Clinical Laboratory, Hengshui Fifth People's Hospital, Hengshui City, 053000, People's Republic of China
| | - Feng-Lian Li
- Department of Clinical Laboratory, Hengshui Fifth People's Hospital, Hengshui City, 053000, People's Republic of China
| | - Li-Xin Du
- Department of Clinical Laboratory, Hengshui Fifth People's Hospital, Hengshui City, 053000, People's Republic of China
| | - Jun-Fang Liu
- Department of Pathology, Hengshui Fifth People's Hospital, Hengshui City, 053000, People's Republic of China
| | - Li-Gang Huo
- Department of Clinical Laboratory, Hengshui Fifth People's Hospital, Hengshui City, 053000, People's Republic of China
| | - Shu-Qing Li
- Department of cardiothoracic surgery, Hengshui Fifth People's Hospital, Hengshui City, 053000, People's Republic of China
| | - Bin Tian
- Department of Clinical Laboratory, Hengshui Fifth People's Hospital, Hengshui City, 053000, People's Republic of China
| |
Collapse
|
22
|
Yi L, Liu J, Deng M, Zuo H, Li M. Emodin inhibits viability, proliferation and promotes apoptosis of hypoxic human pulmonary artery smooth muscle cells via targeting miR-244-5p/DEGS1 axis. BMC Pulm Med 2021; 21:252. [PMID: 34332565 PMCID: PMC8325255 DOI: 10.1186/s12890-021-01616-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2021] [Accepted: 07/21/2021] [Indexed: 12/16/2022] Open
Abstract
OBJECTIVE This study aimed to determine the effects of emodin on the viability, proliferation and apoptosis of human pulmonary artery smooth muscle cells (PASMCs) under hypoxia and to explore the underling molecular mechanisms. METHODS PASMCs were cultured in a hypoxic environment (1% oxygen) and then treated with emodin. Cell viability, proliferation and apoptosis were evaluated using CCK-8 assay, EdU staining assay, western blot and Mito-tracker red CMXRos and Annexin V-FITC apoptosis detection assay. The microRNA (miRNA)/mRNA and protein expression levels were assessed by quantitative real-time PCR and western blotting, respectively. Based on transcriptomics and proteomics were used to identify potential signaling pathways. Luciferase reporter assay was utilized to examine the interaction between miR-244-5p and DEGS1. RESULTS Emodin at 40 and 160 µM concentration-dependently suppressed cell viability, proliferation and migration, but enhanced cell apoptosis of PASMCs under hypoxia. Transcriptomic and proteomic analysis revealed that emodin could attenuate the activity of PI3K/Akt signaling in PASMCs under hypoxia. In addition, delta 4-desaturase, sphingolipid 1 (DEGS1) was found to be a direct target of miR-244-5p. Emodin could significantly up-regulated miR-244-5p expression and down-regulated DEGS1 expression in PASMCs under hypoxia. Furthermore, emodin-mediated effects on cell viability, migration, apoptosis and PI3K/Akt signaling activity of PASMCs under hypoxia were significantly attenuated by miR-244-5p knockdown. CONCLUSIONS Our results indicated that emodin suppressed cell viability, proliferation and migration, promoted cell apoptosis of PASMCs under hypoxia via modulating miR-244-5p-mediated DEGS1/PI3K/Akt signaling pathway. MiR-244-5p/DEGS1 axis was initially investigated in this current study, which is expected to further the understanding of the etiology of pulmonary arterial hypertension.
Collapse
Affiliation(s)
- Li Yi
- Special Medical Service Center, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282 China
| | - JunFang Liu
- Pulmonary and Critical Care Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, 510282 China
| | - Ming Deng
- Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, NO.12, Langshan Road, Nanshan District, Shenzhen, 518057 Guangdong China
| | - Huihua Zuo
- Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, NO.12, Langshan Road, Nanshan District, Shenzhen, 518057 Guangdong China
| | - Mingyan Li
- Department of Cardiology, The Second Affiliated Hospital of Guangzhou Medical University, NO. 250 Changgangdong Road, Guangzhou, 510260 Guangdong China
| |
Collapse
|
23
|
Lin J, Ji XJ, Wang AY, Liu JF, Liu P, Zhang M, Qi ZL, Guo DC, Bellomo R, Bagshaw SM, Wald R, Gallagher M, Duan ML. Corrigendum to "Timing of continuous renal replacement therapy in severe acute kidney injury patients with fluid overload: A retrospective cohort study" [J Crit Care. 2021 Aug; 64: 226-236]. J Crit Care 2021; 66:191. [PMID: 34274206 DOI: 10.1016/j.jcrc.2021.07.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- J Lin
- Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, China
| | - X J Ji
- Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, China
| | - A Y Wang
- The George Institute for Global Health, Newtown, UNSW, Australia; Concord Clinical School, The University of Sydney, Australia; Department of Renal Medicine, Concord Repatriation General Hospital, Australia.
| | - J F Liu
- Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, China
| | - P Liu
- Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, China
| | - M Zhang
- Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, China
| | - Z L Qi
- Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, China
| | - D C Guo
- Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, China
| | - R Bellomo
- The George Institute for Global Health, Newtown, UNSW, Australia; Department of Intensive Care, Austin Hospital, Australia
| | - S M Bagshaw
- Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
| | - R Wald
- Division of Nephrology, St. Michael's Hospital, University of Toronto, Li Ka Shing Knowledge Institute, Toronto, ON, Canada
| | - M Gallagher
- The George Institute for Global Health, Newtown, UNSW, Australia; Concord Clinical School, The University of Sydney, Australia; Department of Renal Medicine, Concord Repatriation General Hospital, Australia
| | - M L Duan
- Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, China.
| |
Collapse
|
24
|
Zhao Y, Cheng JN, Yang DZ, Liu JF. [Endoscopic resection of recurrent nasal inverted papilloma]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2021; 56:797. [PMID: 34344114 DOI: 10.3760/cma.j.cn115330-20210303-00104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Y Zhao
- Department of Otorhinolaryngology, China-Japan Friendship Hospital, Beijing 100029, China
| | - J N Cheng
- Department of Otorhinolaryngology, China-Japan Friendship Hospital, Beijing 100029, China
| | - D Z Yang
- Department of Otorhinolaryngology, China-Japan Friendship Hospital, Beijing 100029, China
| | - J F Liu
- Department of Otorhinolaryngology, China-Japan Friendship Hospital, Beijing 100029, China
| |
Collapse
|
25
|
Lin J, Ji XJ, Wang AY, Liu JF, Liu P, Zhang M, Qi ZL, Guo DC, Bellomo R, Bagshaw SM, Wald R, Gallagher M, Duan ML. Timing of continuous renal replacement therapy in severe acute kidney injury patients with fluid overload: A retrospective cohort study. J Crit Care 2021; 64:226-236. [PMID: 34034218 DOI: 10.1016/j.jcrc.2021.04.017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2021] [Revised: 04/29/2021] [Accepted: 04/30/2021] [Indexed: 01/20/2023]
Abstract
PURPOSE We aimed to evaluate the association of early versus late initiation of Continuous renal replacement therapy (CRRT) with mortality in patients with fluid overload. METHODS This was a retrospective cohort study of patients with fluid overload (FO) treated with CRRT due to severe acute kidney injury (AKI) between January 2015 and December 2017 in a mixed medical intensive care unit of a teaching hospital in Beijing, China. Patients were divided into early (≤15 h) and late (>15 h) groups based on the median time from ICU admission to CRRT initiation. The primary outcome was all-cause mortality at day 60. Multivariable Cox model analysis was used for analysis. RESULTS The study patients were male predominant (84/150) with a mean age of 64.8 ± 16.7 years. The median FO value before CRRT initiation was 10.1% [6.2-16.1%]. The 60-day mortality rates in the early vs the late CRRT groups were 53.9% and 73%, respectively. On multivariable Cox modelling, the late initiation of CRRT was independently associated with an increased risk of death at 60 days (HR 1.75, 95% CI 1.11-2.74, p = 0.015). CONCLUSIONS Early initiation of CRRT was independently associated with survival benefits in severe AKI patients with fluid overload.
Collapse
Affiliation(s)
- J Lin
- Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, China
| | - X J Ji
- Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, China
| | - A Y Wang
- The George Institute for Global Health, Newtown, Australia; Concord Clinical School, The University of Sydney, Australia; Department of Renal Medicine, Concord Repatriation General Hospital, Australia.
| | - J F Liu
- Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, China
| | - P Liu
- Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, China
| | - M Zhang
- Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, China
| | - Z L Qi
- Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, China
| | - D C Guo
- Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, China
| | - R Bellomo
- The George Institute for Global Health, Newtown, Australia; Department of Intensive Care, Austin Hospital, Australia
| | - S M Bagshaw
- Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
| | - R Wald
- Division of Nephrology, St. Michael's Hospital, University of Toronto, Li Ka Shing Knowledge Institute, Toronto, ON, Canada
| | - M Gallagher
- The George Institute for Global Health, Newtown, Australia; Concord Clinical School, The University of Sydney, Australia; Department of Renal Medicine, Concord Repatriation General Hospital, Australia
| | - M L Duan
- Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, China.
| |
Collapse
|
26
|
Abstract
Autosomal dominant hypocalcified amelogenesis imperfecta (ADHCAI; OMIM #130900) is a genetic disorder exhibiting severe hardness defects and reduced fracture toughness of dental enamel. While the condition is nonsyndromic, it can be associated with other craniofacial anomalies, such as malocclusions and delayed or failed tooth eruption. Truncation mutations in FAM83H (OMIM *611927) are hitherto the sole cause of ADHCAI. With human genetic studies, Fam83h knockout and mutation-knock-in mouse models indicated that FAM83H does not serve a critical physiologic function during enamel formation and suggested a neomorphic mutation mechanism causing ADHCAI. The function of FAM83H remains obscure. FAM83H has been shown to interact with various isoforms of casein kinase 1 (CK1) and keratins and to mediate organization of keratin cytoskeletons and desmosomes. By considering FAM83H a scaffold protein to anchor CK1s, further molecular characterization of the protein could gain insight into its functions. In this study, we characterized 9 kindreds with ADHCAI and identified 3 novel FAM83H truncation mutations: p.His437*, p.Gln459*, and p.Glu610*. Some affected individuals exhibited hypoplastic phenotypes, in addition to the characteristic hypocalcification enamel defects, which have never been well documented. Failed eruption of canines or second molars in affected persons was observed in 4 of the families. The p.Glu610* mutation was located in a gap area (amino acids 470 to 625) within the zone of previously reported pathogenic variants (amino acids 287 to 694). In vitro pull-down studies with overexpressed FAM83H proteins in HEK293 cells demonstrated an interaction between FAM83H and SEC16A, a protein component of the COP II complex at endoplasmic reticulum exit sites. The interaction was mediated by the middle part (amino acids 287 to 657) of mouse FAM83H protein. Results of this study significantly extended the phenotypic and genotypic spectrums of FAM83H-associated ADHCAI and suggested a role for FAM83H in endoplasmic reticulum-to-Golgi vesicle trafficking and protein secretion (dbGaP phs001491.v1.p1).
Collapse
Affiliation(s)
- S K Wang
- Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan, Ann Arbor, MI, USA.,Department of Dentistry, School of Dentistry, National Taiwan University, Jhongjheng District, Taipei City, Taiwan
| | - H Zhang
- Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan, Ann Arbor, MI, USA
| | - C Y Hu
- Department of Prosthodontics, National Taiwan University Hospital, Jhongjheng District, Taipei City, Taiwan
| | - J F Liu
- Division of Pediatric Dentistry, Department of Stomatology, Taichung Veterans General Hospital, Xitun District, Taichung City, Taiwan
| | - S Chadha
- Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan, Ann Arbor, MI, USA
| | - J W Kim
- Department of Pediatric Dentistry and Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Republic of Korea.,Department of Molecular Genetics and Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Republic of Korea
| | - J P Simmer
- Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan, Ann Arbor, MI, USA
| | - J C C Hu
- Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan, Ann Arbor, MI, USA
| |
Collapse
|
27
|
Liu JF, Zhao JH, Wang YB, Zhao Y, Chen ZY, Han J. [Diagnosis and treatment of qualitative olfactory dysfunction]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2020; 55:998-1001. [PMID: 33036522 DOI: 10.3760/cma.j.cn115330-20200122-00047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Affiliation(s)
- J F Liu
- Department of Otorhinolaryngology, China Japan Friendship Hospital, Beijing 100029, China
| | - J H Zhao
- Department of Otorhinolaryngology, China Japan Friendship Hospital, Beijing 100029, China
| | - Y B Wang
- Department of Otorhinolaryngology, China Japan Friendship Hospital, Beijing 100029, China
| | - Y Zhao
- Department of Otorhinolaryngology, China Japan Friendship Hospital, Beijing 100029, China
| | - Z Y Chen
- Department of Otorhinolaryngology, China Japan Friendship Hospital, Beijing 100029, China
| | - J Han
- Department of Otorhinolaryngology, China Japan Friendship Hospital, Beijing 100029, China
| |
Collapse
|
28
|
Wang J, Huang L, Chen X, Zhou L, You J, Xu DM, Liu JF. [Predicting the prognosis for severe brain injury patients: short-latency somatosensory evoked potential combined with electroencephalogram reactivity]. Zhonghua Yi Xue Za Zhi 2020; 100:2924-2928. [PMID: 32993252 DOI: 10.3760/cma.j.cn112137-20200217-00305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the the effectiveness of using short-latency somatosensory evoked potential(SLSEP) combined with electroencephalogram(EEG) reactivity to predict the prognosis of severe brain injury(SBI) patients. Methods: Consecutive patients with SBI admitted in neurosurgery intensive care unit(NSICU) at Xiangya Hospital of Central South University from July 2018 to January 2019 were prospectively collected. SLSEP and EEG were recorded in these patients in NSICU within two weeks after injury onset. EEG reactivity(EEG-R) was tested during EEG signal stabilization. In addition, the concentrations of serum neuron-specific enolase (NSE) and S100 protein were also detected. All patients were evaluated with Glasgow Outcome Scale(GOS) during 12 months' follow-up. GOS grade 3 to 5 was defined as favorable group, and GOS grade 1 to 2 was defined as unfavorable group. The association of relevant predictors with patient's prognosis was assessed. The area under the receiver operating characteristic (ROC) curve (AUC) was used to evaluate each potential predictor. Results: Forty-three patients were included in the study, with 26 patients of favorable outcomes and 17 patients with unfavorable prognosis. Univariate analysis revealed that the Glasgow Coma Scale (GCS) score, the concentration of serum NSE, EEG-R, the amplitude of SLSEP were all associated with the prognosis after 12 months' follow-up. Moreover, the AUC for prediction of favorable prognosis by GCS, NSE, EEG-R, SLSEP was 0.661(95%CI: 0.493-0.829), 0.697(95%CI: 0.531-0.862), 0.718(95%CI: 0.557-0.879) and 0.758(95%CI: 0.609-0.907) respectively. However, there was no significant difference of age, gender, pupillary light reflex and S100 protein between the two groups. Furthermore, multiple logistic regression analysis showed that only SLSEP amplitude (OR=2.058, 95%CI: 0.867-4.888) and EEG-R(OR=3.748, 95%CI: 0.857-16.394) were independent predictors of favorable prognosis, and the prognostic model containing these two variables yielded an predictive performance with an AUC of 0.798. Conclusion: The higher amplitude of SLSEP and the existence of EEG-R are predictors of good prognosis in SBI patients, and the combined use of SLSEP and EEG-R in predicting the prognosis of SBI patients is more reliable.
Collapse
Affiliation(s)
- J Wang
- Neurosurgery Intensive Care Unit, Xiangya Hospital of Central South University, Changsha 410008, China
| | - L Huang
- Department of Critical Care Medicine, Xiangya Hospital of Central South University, Changsha 410008, China
| | - X Chen
- Neurosurgery Intensive Care Unit, Xiangya Hospital of Central South University, Changsha 410008, China
| | - L Zhou
- Neurosurgery Intensive Care Unit, Xiangya Hospital of Central South University, Changsha 410008, China
| | - J You
- Neurosurgery Intensive Care Unit, Xiangya Hospital of Central South University, Changsha 410008, China
| | - D M Xu
- Department of Critical Care Medicine, Xiangya Hospital of Central South University, Changsha 410008, China
| | - J F Liu
- Neurosurgery Intensive Care Unit, Xiangya Hospital of Central South University, Changsha 410008, China
| |
Collapse
|
29
|
Zhang Q, Ding X, Liu YH, Liu JF, Xu XZ, Ying QJ, Dai Y, Cao J. [Establishment of a recombinase-aided isothermal amplification assay for nucleic acid detection of Angiostrongylus cantonensis]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2020; 32:350-354. [PMID: 32935507 DOI: 10.16250/j.32.1374.2020091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVE To establish a recombinase-aided isothermal amplification (RAA) assay for the nucleic acid detection of Angiostrongylus cantonensis. METHODS The internal transcribed spacer-1 (ITS1) gene sequence of A. cantonensis was used as the detection target sequence, and the specific primers and probes were designed and synthesized, followed by screening of the primers and probes with the highest specificity, to establish the basic and fluorescent RAA assay for nucleic acid detection of A. cantonensis. The sensitivity of the fluorescent RAA assay was evaluated by using the target gene fragment sequence-contained recombinant plasmids at various copy numbers and the genomic DNA from A. cantonensis as the template DNA samples, and the specificity of the fluorescent RAA assay was evaluated by using the genomic DNA from A. cantonensis, Schistosoma mansoni, Ascaris lumbricoides, Clonorchis sinensis, Echinococcus granulosus and Ancylostoma duodenale, as well as Pomacea canaliculata and Biomphalaria straminea snail tissues as the template DNA samples. RESULTS A fluorescent RAA assay was successfully established for nucleic acid detection of A. cantonensis, which achieved real-time amplification of the specific DNA fragment of A. cantonensis within 20 min at 37 ℃. By using the target gene fragment sequence-contained recombinant plasmids at various copy numbers and the genomic DNA from A. cantonensis as the DNA templates, the lowest detection limits of the fluorescent RAA assay were 10 copies/μL of recombinant plasmids and 100 pg/μL of genomic DNA, respectively. The fluorescent RAA assay was negative for detection of the genomic DNA from A. cantonensis, S. mansoni, A. lumbricoides, C. sinensis, E. granulosus, A. duodenale, and P. canaliculata and B. straminea snail tissues. CONCLUSIONS A simple, rapid fluorescent RAA assay has been successfully established, which has a high sensitivity and specificity for the nucleic acid detection of A. cantonensis.
Collapse
Affiliation(s)
- Q Zhang
- National Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Public Health Research Center, Jiangnan University, Wuxi 214064, China
| | - X Ding
- National Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Public Health Research Center, Jiangnan University, Wuxi 214064, China
| | - Y H Liu
- Jiangsu Qitian Gene Technology Co., Ltd., China
| | - J F Liu
- National Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Public Health Research Center, Jiangnan University, Wuxi 214064, China
| | - X Z Xu
- National Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Public Health Research Center, Jiangnan University, Wuxi 214064, China
| | - Q J Ying
- Jiangsu Qitian Gene Technology Co., Ltd., China
| | - Y Dai
- National Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Public Health Research Center, Jiangnan University, Wuxi 214064, China
| | - J Cao
- National Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Public Health Research Center, Jiangnan University, Wuxi 214064, China
| |
Collapse
|
30
|
Li XC, Zhou YB, Si KY, Li HT, Zhang L, Zhang YL, Liu JF, Liu JM. [Relationship of plasma vitamin A levels between neonates and pregnant women in third trimester]. Beijing Da Xue Xue Bao Yi Xue Ban 2020; 52:464-469. [PMID: 32541979 DOI: 10.19723/j.issn.1671-167x.2020.03.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
OBJECTIVE To study the correlation of plasma vitamin A (VitA) levels between neonates and pregnant women in third trimester. METHODS A total of 688 pregnant women were recruited in Yuanshi and Laoting counties of Hebei Province, from May to June 2009. Venous blood samples of women before delivery and cord blood samples of newborns were collected and measured for retinol (retinol concentration was used to reflect VitA level) using high performance liquid chromatography assay. According to venous blood plasma retinol concentration, maternal VitA nutritional status was divided into deficiency (<0.70 μmol/L), marginal deficiency (0.70-<1.05 μmol/L), and sufficiency (≥1.05 μmol/L). According to cord blood plasma retinol concentration, neonatal VitA nutritional status was divided into deficiency (<0.35 μmol/L), marginal deficiency (0.35-<0.70 μmol/L), and sufficiency (≥0.70 μmol/L); neonatal VitA relative deficiency was further defined as cord blood plasma retinol concentration lower than the 10th percentile. VitA placental transport ratio was defined as retinol concentration in the neonates divided by that in pregnant women. Multivariable fractional polynomials (MFP) model and Pearson correlation were used to study the dose-response relationship between maternal and neonatal plasma VitA levels, Logistic regression model to estimate the effect of maternal VitA nutritional status on neonatal VitA deficiency, and MFP model and Spearman correlation to describe the relationship between maternal VitA level and VitA placental transport ratio. RESULTS The average retinol concentration of the pregnant women was (1.15±0.30) μmol/L, and the prevalence of VitA deficiency and marginal deficiency were 4.5% and 37.8%, respectively. Average retinol concentration of the neonates was (0.78±0.13) μmol/L, and no neonates were VitA deficiency, 28.2% of the neonates were marginal deficiency. After multivariable adjustment, the VitA level of the neonates was positively and linearly related to maternal VitA level (pm=1, P<0.05), with the corresponding Pearson correlation coefficient of 0.13 (P<0.01). As compared with the women with sufficient VitA, those with VitA deficiency (crude OR=2.20, 95%CI:1.04-4.66) and marginal deficiency (crude OR=1.43, 95%CI:1.01-2.02) had higher risks to deliver neonates with VitA marginal deficiency; while the risks turned to be non-significant after multivariable adjustment. The pregnant women with VitA deficiency had higher risk to deliver neonates with relative VitA deficiency before and after multivariable adjustment (crude OR=3.02, 95%CI:1.21-7.50; adjusted OR=2.76, 95%CI:1.05-7.22). The maternal VitA level was negatively and non-linearly correlated with placental transport ratio (pm= -0.5, P<0.05), with corresponding adjusted Spearman correlation coefficient of -0.82 (P<0.001). CONCLUSION There was a positive linear dose-response relationship between VitA levels of newborns and pregnant women in third trimester, indicating that neonatal VitA storing levels at birth was affected by maternal VitA nutritional status.
Collapse
Affiliation(s)
- X C Li
- Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.,Institute of Reproductive and Child Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing 100191, China
| | - Y B Zhou
- Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.,Institute of Reproductive and Child Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing 100191, China
| | - K Y Si
- Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.,Institute of Reproductive and Child Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing 100191, China
| | - H T Li
- Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.,Institute of Reproductive and Child Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing 100191, China
| | - L Zhang
- Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.,Institute of Reproductive and Child Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing 100191, China
| | - Y L Zhang
- Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.,Institute of Reproductive and Child Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing 100191, China
| | - J F Liu
- Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.,Institute of Reproductive and Child Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing 100191, China
| | - J M Liu
- Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.,Institute of Reproductive and Child Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing 100191, China
| |
Collapse
|
31
|
Liu JF, Shen T, Zhang YT. Posterior reversible encephalopathy syndrome and heart failure tacrolimus-induced after liver transplantation: A case report. World J Clin Cases 2020; 8:2870-2875. [PMID: 32742997 PMCID: PMC7360704 DOI: 10.12998/wjcc.v8.i13.2870] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/01/2020] [Revised: 05/07/2020] [Accepted: 06/13/2020] [Indexed: 02/05/2023] Open
Abstract
BACKGROUND Patients undergoing liver transplantation can develop posterior reversible encephalopathy syndrome (PRES) and acute heart failure (HF) in the post-operative period. But PRES with HF caused by tacrolimus has rarely been described.
CASE SUMMAR A 40-year-old female patient who had a normal preoperative cardiac and neural evaluation developed PRES with acute heart failure tacrolimus-induced after liver transplantation. The challenges associated with both diagnosis and management in the setting of a newly implanted graft are discussed.
CONCLUSION Tacrolimus can induce neurotoxicity and then cardiac toxicity. Magnetic resonance imaging, echocardiography, and increased brain natriuretic peptide may be predictive of post-operative PRES with acute heart failure. Further investigations are necessary to verify this finding.
Collapse
Affiliation(s)
- Jun-Fang Liu
- Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Province, China
| | - Tian Shen
- Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Province, China
| | - Yun-Tao Zhang
- Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Province, China
| |
Collapse
|
32
|
Mao FZ, Xu XZ, Jin XL, Liu JF, Ni BX, Dai Y, Cao J. [Epidemic trend and control progress of soil-transmitted nematodiasis in Jiangsu Province]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2020; 32:453-458. [PMID: 33185054 DOI: 10.16250/j.32.1374.2020141] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Soil-transmitted nematodiasis was once widely prevalent in Jiangsu Province, which seriously threatened human health and hindered socioeconomic development. The control efforts over decades resulted in a remarkable decline in the prevalence of soil-transmitted nematode human infections in Jiangsu Province, with a reduction from 59.32% in 1989 to 0.12% in 2019, and the human prevalence remains at < 0.5% since 2013. Since 1987, an integrated strategy has been adopted for the control of soil-transmitted nematodiasis in Jiangsu Province; however, the core interventions varies at different stages, which mainly include deworming, water and sanitation service improvement, health education, and monitoring and assessment. The criteria of effective soil-transmitted nematodiasis control had been achieved in all epidemic counties (districts) of Jiangsu Province by 2019. Further actions to strengthen health education and monitoring and implement precision control measures are required to consolidate the achievements of soil-transmitted nematodiasis control and eliminate the harm of soil-transmitted nematodiasis to humans. This review summarizes the epidemiology, control progress and evolution of control strategy of soil-transmitted nematodiasis in Jiangsu Province.
Collapse
Affiliation(s)
- F Z Mao
- Key Laboratory of National Health Commission on Parasitic Disease Control and Prevention; Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology; Jiangsu Institute of Parasitic Diseases; Public Health Research Center, Jiangnan University, Wuxi 214064, China
| | - X Z Xu
- Key Laboratory of National Health Commission on Parasitic Disease Control and Prevention; Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology; Jiangsu Institute of Parasitic Diseases; Public Health Research Center, Jiangnan University, Wuxi 214064, China
| | - X L Jin
- Key Laboratory of National Health Commission on Parasitic Disease Control and Prevention; Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology; Jiangsu Institute of Parasitic Diseases; Public Health Research Center, Jiangnan University, Wuxi 214064, China
| | - J F Liu
- Key Laboratory of National Health Commission on Parasitic Disease Control and Prevention; Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology; Jiangsu Institute of Parasitic Diseases; Public Health Research Center, Jiangnan University, Wuxi 214064, China
| | - B X Ni
- Key Laboratory of National Health Commission on Parasitic Disease Control and Prevention; Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology; Jiangsu Institute of Parasitic Diseases; Public Health Research Center, Jiangnan University, Wuxi 214064, China
| | - Y Dai
- Key Laboratory of National Health Commission on Parasitic Disease Control and Prevention; Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology; Jiangsu Institute of Parasitic Diseases; Public Health Research Center, Jiangnan University, Wuxi 214064, China
| | - J Cao
- Key Laboratory of National Health Commission on Parasitic Disease Control and Prevention; Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology; Jiangsu Institute of Parasitic Diseases; Public Health Research Center, Jiangnan University, Wuxi 214064, China
| |
Collapse
|
33
|
Fang CH, Zhang P, Zhou WP, Zhou J, Dai CL, Liu JF, Jia WD, Liang X, Zeng SL, Wen S. [Efficacy of three-dimensional visualization technology in the precision diagnosis and treatment for primary liver cancer: a retrospective multicenter study of 1 665 cases in China]. Zhonghua Wai Ke Za Zhi 2020; 58:375-382. [PMID: 32393005 DOI: 10.3760/cma.j.cn112139-20200220-00105] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
Objective: To evaluate the efficacy of three-dimensional(3D) visualization technology in the precision diagnosis and treatment for primary liver cancer. Methods: A total of 1 665 patients with primary liver cancer who admitted to seven medical centers in China between January 2009 to January 2019, diagnosed and treated by 3D visualization protocol were analyzed, and their clinical data were retrospectively reviewed. There were 1 255 males(75.4%) and 410 females(24.6%), with age of (52.9±11.9) years (range: 18 to 86 years). The acquisition of high-quality CT images with submillimeter spatial resolution were conducted using a quality control system. By means of homogenization methods, 3D reconstruction and 3D visualization analysis were performed. Postoperative observation: pathology reports, microvascular invasion, perioperative complications and follow-up. SPSS 25.0 statistical software was used for statistical description and analysis of clinical data. Kaplan-Meier curve was used to calculate overall survival and disease-free survival rate. Results: (1)In the sample of 1 265 patients, 3D reconstructed models clearly displayed as follows. tumor size: ≤2 cm in 155 cases (9.31%), >2 cm to 5 cm in 551 cases (33.09%), >5 cm to 10 cm in 636 cases (38.20%), >10 cm in 323 cases (19.40%). (2) Classification of hepatic blood vessels. Hepatic artery: type Ⅰ(normal type) in 1 494 cases(89.73%),variant hepatic artery in 171 cases (10.27%), including type Ⅱ in 35 cases, type Ⅲ in 38 cases, and other types in 98 cases. Hepatic vein: type Ⅰ (normal) in 1 195 cases (71.77%),variant hepatic veins in 470 cases(28.23%), including type Ⅱ in 376 cases and type Ⅲ in 94 cases. Portal vein:normal type in 1 315 cases (78.98%), variant portal veins in 350 cases (21.02%), including type Ⅰ in 189 cases, type Ⅱin 103 cases, type Ⅲ in 50 cases, type Ⅳ in 8 cases. Hepatic artery variation coexisting with portal vein variation in 24 cases (1.44%). Hepatic vein variation coexisting with portal vein variation in 113 cases (6.79%). Three types of vascular variation in 4 cases (0.24%), including coexistence of type Ⅱ hepatic artery variation or type Ⅰ portal vein variation with type Ⅲ hepatic vein variation in 2 cases,coexistence of type Ⅲ hepatic artery variation or type Ⅲ portal vein variation with type Ⅱ hepatic vein variation in 2 cases. (3) Preoperative liver volume calculation:1 499.3 (514.4)ml (range:641.7 to 6 637.0 ml) of total liver volume, including 479.1 (460.1) ml (range:10.5 to 2 086.8 ml) for liver resection and 959.9 (460.4)ml (range:306.1 to 5 638.0 ml) for residual function. (4)Operative methods: anatomical hepatectomy in 1 458 cases (87.57%); non-anatomic hepatectomy in 207 cases (12.43%). (5)the median operation time was 285(165)minutes (range: 40 to720 minutes). (6)The median intraoperative blood loss was 200(250)ml (range:10 to 4 200 ml) and 346 cases (20.78%) had intraoperative transfusion. (7)Pathology reports: hepatocellular carcinoma in 1 371 cases (82.34%), cholangiocarcinoma in 260 cases (15.62%) and mixed hepatocellular carcinoma in 34 cases (2.04%). Microvascular invasion: M0 in 199 cases, M1 in 64 cases, and M2 in 27 cases. (8)Postoperative complications in 207 cases (12.43%), including Clavien-Dindo grade Ⅰ or Ⅱ in 57 cases, grade Ⅲ or Ⅳ in 147 cases and grade Ⅴ in 3 cases.There were 13 cases (0.78%) of liver failure and 3 cases (0.18%) of perioperative death. (9) The follow-up time was 3.0 to 96.0 months, with a median time of 21.0(17.8) years. The overall 3-year survival and disease-free survival rates were 80.0% and 56.5%, respectively. The overall 5-year survival and disease-free survival rates were 59.7% and 30.0%, respectively. Conclusion: 3D visualization technology plays an important role in realizing accurate diagnosis of anatomical location and morphology of primary liver cancer, improving the success rate of surgery and reducing the incidence of complications.
Collapse
Affiliation(s)
- C H Fang
- First Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangdong Provincial Clinical and Engineering Center of Digital Medicine, Guangzhou 510282, China
| | - P Zhang
- First Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangdong Provincial Clinical and Engineering Center of Digital Medicine, Guangzhou 510282, China
| | - W P Zhou
- Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Affiliated to Naval Medical University, Shanghai 200433, China
| | - J Zhou
- Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200438, China
| | - C L Dai
- Department of Hepatobiliary Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, China
| | - J F Liu
- Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China
| | - W D Jia
- Department of General Surgery, First Affiliated Hospital of University of Science and Technology of China, Hefei 230001, China
| | - X Liang
- Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, China
| | - S L Zeng
- First Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangdong Provincial Clinical and Engineering Center of Digital Medicine, Guangzhou 510282, China
| | - S Wen
- First Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangdong Provincial Clinical and Engineering Center of Digital Medicine, Guangzhou 510282, China
| |
Collapse
|
34
|
Mao YS, Gao SG, Wang Q, Shi XT, Li Y, Gao WW, Guan FS, Li XF, Han YT, Liu YY, Liu JF, Zhang K, Liu SY, Fu XN, Fang WT, Chen LQ, Wu QC, Xiao GM, Chen KN, Jiao GG, Zhang SJ, Mao WM, Rong TH, Fu JH, Tan LJ, Chen C, Xu SD, Guo SP, Yu ZT, Hu J, Hu ZD, Yang YK, Ding NN, Yang D, He J. [Epidemiological characteristic and current status of surgical treatment for esophageal cancer by analysis of national registry database]. Zhonghua Zhong Liu Za Zhi 2020; 42:228-233. [PMID: 32252202 DOI: 10.3760/cma.j.cn112152-20191112-00729] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Objective: To investigate the epidemiological characteristics and current status of surgical management for esophageal cancer in China. Methods: A national database was setup through a network platform. The clinical data of esophageal cancer treated by surgery was collected from 70 major hospitals in China between January 2009 and December 2014. Results: Complete data of 8 181 cases of esophageal cancer patients who underwent surgery were recorded in the database and recruited in the analysis. Among them, 6 052 cases were male and 2 129 were female, the average age was 60.5 years.The epidemiological investigation results showed that 148 cases (1.8%) had history of psychological trauma, 7 527 cases (92.0%) were lower social economic status, 5 072 cases (62.0%) were short of fresh vegetables and fruits, 6 544 cases (80.0%) ate rough food frequently, 3 722 cases (45.5%) drank untreated water directly from lake or river or shallow well, 3 436 cases (42.0%) had a unhealthy eating habit, including habits of eating food fast (507 cases, 6.2%), eating hot food or drinking hot tea/soup (998 cases, 12.2%), eating fried food (1 939 cases, 23.7%), 4 410 cases (53.9%) had the habits of smoking cigarettes and 2 822 cases (34.5%) drank white wine frequently.The pathological results showed that 7 813 cases (95.5%) were squamous cell carcinoma, 267 cases were adenocarcinoma (3.3%), 25 cases were adenosquamous cell carcinoma (0.3%) and 50 cases were small cell carcinoma (0.6%). A total of 1 800 cases (22.0%) received preoperative neoadjuvant therapy due to locally advanced disease or difficulty of resection. The esophagectomies were performed through left thoracotomy approach in 5 870 cases (71.8%), through right chest approach in 2 215 cases (27.1%), and the remain 96 cases (1.2%) received surgery though other approaches.A total of 8 001 cases (97.8%) underwent radical resection, the other 180 cases (2.2%) received palliative resection. The 30-day postoperative mortality rate was 0.5%, the overall ≥ grade Ⅱ postoperative complication rate was 11.6% (951 cases). The 1-yr, 3-yr, and 5-yr overall actual survival rates were 82.6%, 61.6%, and 52.9%, respectively. Conclusions: The data analysis of the national database for esophageal cancer shows that bad eating habits or eating rough food without enough nutrients, lower social and economic status, drinking white wine and smoking cigarettes frequently may be correlated with tumorigenesis of esophageal cancer. However, strong evidences produced by prospective observation studies are needed. Overall, the long-term survival of esophageal cancer patients has been improved gradually due to the application of advanced surgical techniques and reasonable multimodality treatment.
Collapse
Affiliation(s)
- Y S Mao
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - S G Gao
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - Q Wang
- Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China
| | - X T Shi
- Department of Thoracic Surgery, Anyang Cancer Hospital, Anyang 455000, China
| | - Y Li
- Department of Thoracic Surgery, Henan Cancer Hospital, Zhengzhou 450003, China
| | - W W Gao
- Department of Thoracic Surgery, Linzhou Renmin Hospital, Linzhou 456550, China
| | - F S Guan
- Department of Thoracic Surgery, Linzhou Cancer Hospital, Linzhou 456550, China
| | - X F Li
- Department of Thoracic Surgery, affiliated Tandu Hospital of the Fourth Military University, Xian 710038, China
| | - Y T Han
- Department of Thoracic Surgery, Sichuan Cancer Hospital, Chengdu 610041, China
| | - Y Y Liu
- Department of Thoracic Surgery, Liaoning Cancer Hospital, Shenyang 110042, China
| | - J F Liu
- Department of Thoracic Surgery, the Fourth Hospital, Hebei Medical University, Shijiazhuang 050011, China
| | - K Zhang
- Department of Thoracic Surgery, Jining Renmin Hospital, Jining 272001, China
| | - S Y Liu
- Department of Thoracic Surgery, Fujian Cancer Hospital, Fujian Medical University, Fuzhou 350014, China
| | - X N Fu
- Department of Thoracic Surgery, Tongji Hospital, Tongji University, Wuhan 430030, China
| | - W T Fang
- Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai 200030, China
| | - L Q Chen
- Department of Thoracic Surgery, West China Hospital of Sichuan University, Chengdu 610041, China
| | - Q C Wu
- Department of Thoracic Surgery, the First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China
| | - G M Xiao
- Department of Thoracic Surgery, Hunan Cancer Hospital, Changsha 410000, China
| | - K N Chen
- Department of Thoracic Surgery, Beijing Cancer Hospital, Beijing University, Beijing 100142, China
| | - G G Jiao
- Department of Thoracic Surgery, Linzhou Esophageal Cancer Hospital, Linzhou 456592, China
| | - S J Zhang
- Department of Thoracic Surgery, Jiangsu Renmin Hospital, Nanjing 210029, China
| | - W M Mao
- Department of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou 310022, China
| | - T H Rong
- Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China
| | - J H Fu
- Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China
| | - L J Tan
- Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China
| | - C Chen
- Department of Thoracic Surgery, the Affiliated Union Hospital, Fujian Medical University, Fuzhou 350001, China
| | - S D Xu
- Department of Thoracic Surgery, Heilongjiang Cancer Hospital, Harbin 150081, China
| | - S P Guo
- Department of Thoracic Surgery, Shanxi Cancer Hospital, Taiyuan 030001, China
| | - Z T Yu
- Department of Thoracic Surgery, Tianjin Cancer Hospital, Tianjin 300060, China
| | - J Hu
- Department of Thoracic Surgery, First Affiliated Hospital, Zhejiang University, Hangzhou 310003, China
| | - Z D Hu
- Department of Thoracic Surgery, Jiangsu Cancer Hospital, Nanjing 210009, China
| | - Y K Yang
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - N N Ding
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - D Yang
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - J He
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| |
Collapse
|
35
|
Wang K, Liang ZY, Wang XL, Li Y, Lu YR, Liu JF, Li JH, Xu LM, Chen GQ, Chang P, Cen ZR, Chen X. Continuous positive airway pressure improves respiratory mechanics and efficiency of neural drive in stable COPD: an exploratory study. J Thorac Dis 2020; 12:626-638. [PMID: 32274128 PMCID: PMC7139021 DOI: 10.21037/jtd.2019.12.120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Background Continuous positive airway pressure (CPAP) is a major treatment strategy for severe chronic obstructive pulmonary disease (COPD), especially with respiratory failure. However, it remains inconclusive whether CPAP affects respiratory mechanics and neural drive in stable COPD patients without respiratory failure. Methods Twenty-two COPD patients without respiratory failure received CPAP starting from 4 to 10 cmH2O in 1 cmH2O increments. Respiratory pattern, end expiatory lung volume (EELV), dynamic PEEPi (PEEPidyn), airway resistance (Raw), pressure-time product of diaphragmatic pressure (PTPdi) and esophageal pressure (PTPeso), root mean square (RMS) of diaphragm electromyogram (EMGdi) and ratio of ventilation (Ve) to EMGdi (i.e., Ve/RMS) were measured before and at each level of continue positive airway pressure (CPAP). A subgroup analysis was performed between patients with and without inspiratory muscle weakness. Results Nineteen patients completed the treatment. The respiratory pattern improved significantly after CPAP. Raw, PTPdi, and Pdi decreased significantly. ΔEELV decreased at 4 cmH2O (P<0.05), but increased significantly at >8 cmH2O. PEEPidyn decreased from 2.18±0.98 to 1.37±0.55 cmH2O. RMS increased while Ve/RMS improved significantly after CPAP (P<0.05). Besides, CPAP could significantly improve respiratory mechanics in patients with inspiratory muscle weakness. Conclusions CPAP improves respiratory pattern, PEEPi, Raw, work of breathing and efficiency of neural drive in COPD patients without respiratory failure, but easily increases dynamic pulmonary hyperinflation. These effects on respiratory mechanics are significant in patients with inspiratory muscle weakness.
Collapse
Affiliation(s)
- Kai Wang
- Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.,Department of Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China
| | - Zhen-Yu Liang
- Department of Respiratory Medicine, The State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China
| | - Xi-Long Wang
- Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China
| | - Yun Li
- Department of Respiratory Medicine, Gaozhou People's Hospital, Guangdong 525200, China
| | - Yi-Rong Lu
- Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China
| | - Jun-Fang Liu
- Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China
| | - Jia-Hui Li
- Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China
| | - Li-Mei Xu
- Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China
| | - Guo-Qiang Chen
- Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China
| | - Ping Chang
- Department of Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China
| | - Zhong-Ran Cen
- Department of Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China
| | - Xin Chen
- Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China
| |
Collapse
|
36
|
Liu JF, Chen TY, Chen YL, Zhao YR. [Reply to the comments on 2019 Chinese guidelines for the prevention and treatment of mother-to-child transmission of hepatitis B virus]. Zhonghua Gan Zang Bing Za Zhi 2020; 28:27-30. [PMID: 32023695 DOI: 10.3760/cma.j.issn.1007-3418.2020.01.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- J F Liu
- Department of Infectious Disease, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| | - T Y Chen
- Department of Infectious Disease, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| | - Y L Chen
- Evidence-Based Medicine Center, School of Basic Medical Science, Lanzhou University, Lanzhou 730000, China; WHO Collaborating Centre for Guideline Implementation and Knowledge Translation; Chinese GRADE center; Asia Alliance Guideline
| | - Y R Zhao
- Department of Infectious Disease, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| |
Collapse
|
37
|
Banerjee S, Oza AM, Birrer MJ, Hamilton EP, Hasan J, Leary A, Moore KN, Mackowiak-Matejczyk B, Pikiel J, Ray-Coquard I, Trask P, Lin K, Schuth E, Vaze A, Choi Y, Marsters JC, Maslyar DJ, Lemahieu V, Wang Y, Humke EW, Liu JF. Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study. Ann Oncol 2019; 29:917-923. [PMID: 29401246 DOI: 10.1093/annonc/mdy023] [Citation(s) in RCA: 55] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Background Lifastuzumab vedotin (LIFA) is a humanized anti-NaPi2b monoclonal antibody conjugated to a potent antimitotic agent, monomethyl auristatin E, which inhibits cell division by blocking the polymerization of tubulin. This study is the first to compare an antibody-drug conjugate (ADC) to standard-of-care in ovarian cancer (OC) patients. Patients and methods Platinum-resistant OC patients were randomized to receive LIFA [2.4 mg/kg, intravenously, every 3 weeks (Q3W)] or pegylated liposomal doxorubicin (PLD) (40 mg/m2, intravenously, Q4W). NaPi2b expression and serum CA-125 and HE4 levels were assessed. The primary end point was progression-free survival (PFS) in intent-to-treat (ITT) and NaPi2b-high patients. Results Ninety-five patients were randomized (47 LIFA; 48 PLD). The stratified PFS hazard ratio was 0.78 [95% confidence interval (95% CI), 0.46-1.31; P = 0.34] with a median PFS of 5.3 versus 3.1 months (LIFA versus PLD arm, respectively) in the ITT population, and 0.71 (95% CI, 0.40-1.26; P = 0.24) with a median PFS of 5.3 months versus 3.4 months (LIFA versus PLD arm, respectively) in NaPi2b-high patients. The objective response rate was 34% (95% CI, 22% to 49%, LIFA) versus 15% (95% CI, 7% to 28%, PLD) in the ITT population (P = 0.03), and 36% (95% CI, 22% to 52%, LIFA) versus 14% (95% CI, 6% to 27%, PLD) in NaPi2b-high patients (P = 0.02). Toxicities included grade ≥3 adverse events (AEs) (46% LIFA; 51% PLD), serious AEs (30% both arms), and AEs leading to discontinuation of drug (9% LIFA; 8% PLD). Five (11%) LIFA versus 2 (4%) PLD patients had grade ≥2 neuropathy. Conclusion LIFA Q3W was well tolerated and improved objective response rate with a modest, nonstatistically significant improvement of PFS compared with PLD in platinum-resistant OC. While the response rate for the monomethyl auristatin E-containing ADC was promising, response durations were relatively short, thereby highlighting the importance of evaluating both response rates and duration of response when evaluating ADCs in OC. Clinical trials.gov NCT01991210.
Collapse
Affiliation(s)
- S Banerjee
- Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK
| | - A M Oza
- Princess Margaret Hospital, Toronto, Canada
| | - M J Birrer
- Massachusetts General Hospital, Boston, USA; Harvard Medical School, Boston, USA
| | - E P Hamilton
- Sarah Cannon Research Institute, Nashville, USA; Tennessee Oncology, Nashville, USA
| | - J Hasan
- The Christie Hospital, Manchester, UK
| | - A Leary
- Gustave Roussy Cancer Centre, Paris, France
| | - K N Moore
- University of Oklahoma Health Sciences Center, Oklahoma City, USA
| | | | - J Pikiel
- Regional Center of Oncology, Gdańsk, Poland
| | - I Ray-Coquard
- Centre Léon Bérard Centre Régional de Lutte Contre Le Cancer Rhône Alpes, Lyon, France
| | - P Trask
- Genentech, Inc., South San Francisco, USA
| | - K Lin
- Genentech, Inc., South San Francisco, USA
| | - E Schuth
- Genentech, Inc., South San Francisco, USA
| | - A Vaze
- Genentech, Inc., South San Francisco, USA
| | - Y Choi
- Genentech, Inc., South San Francisco, USA
| | | | | | - V Lemahieu
- Genentech, Inc., South San Francisco, USA
| | - Y Wang
- Genentech, Inc., South San Francisco, USA
| | - E W Humke
- Genentech, Inc., South San Francisco, USA
| | - J F Liu
- Harvard Medical School, Boston, USA; Gynecologic Oncology Program, Dana-Farber Cancer Institute, Boston, USA.
| |
Collapse
|
38
|
Zhang Q, Ding X, Wu XM, Liu YH, Liu JF, Xu XZ, Ying QJ, Cao J, Dai Y. [Establishment and preliminary evaluation of recombinase aided isothermal amplification (RAA) assay for specific nucleic acid detection of Clonorchis sinensis]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2019; 31:468-473. [PMID: 31713373 DOI: 10.16250/j.32.1374.2019178] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVE To establish a recombinase aided isothermal amplification (RAA) assay for detection of Clonorchis sinensis. METHODS The 18S ribosomal RNA (18S rRNA) sequence of C. sinensis was used as the target sequence, and specific primers and probes were designed, synthesized and screened to establish a rapid fluorescent RAA assay for the detection of C. sinensis. Then, the sensitivity of the fluorescent RAA assay was evaluated using the recombinant plasmids containing various copy numbers of DNA fragments and C. sinensis genomic DNA at various concentrations, and the specificity of the fluorescent RAA as say was evaluated using the genomic DNA of Ascaris lumbricoides, Echinococcus granulosus, Schistosoma japonicum, Ancylostoma duodenale and S. mansoni as templates. DNA samples were extracted from the feces containing C. sinensis eggs and freshwater fish containing metacercaria for the fluorescent RAA assay, and the performance for detection of C. sinensis-infected samples was preliminarily assessed in the field. RESULTS A fluorescent RAA assay for detection of C. sinensis was successfully established, which was feasible for specific amplification of C. sinensis genomic DNA at 39 °C within 20 min. The lowest detection limit was 10 copies/μL if the recombinant plasmid containing various copy numbers of DNA fragments was used as a template, and the lowest detection limit was 3 pg/μL if the C. sinensis genomic DNA at various concentrations served as a template. All detections were negative if the genomic DNA of A. lumbricoides, E. granulosus, S. japonicum, A. duodenale, and S. mansoni was used as templates. In addition, the fluorescent RAA assay showed a high performance for the detection of C. sinensis-infected samples in the field, which successfully detected C. sinensis-infected human and rat fecal samples and Pseudorasbora parva samples. CONCLUSIONS A fluorescent RAA assay is successfully established, which is simple, rapid, sensitivity and specific for detection of C. sinensis.
Collapse
Affiliation(s)
- Q Zhang
- National Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi 214064, China.,Public Health Research Center, Jiangnan University, China
| | - X Ding
- National Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi 214064, China.,Public Health Research Center, Jiangnan University, China
| | - X M Wu
- National Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi 214064, China.,Public Health Research Center, Jiangnan University, China
| | - Y H Liu
- Jiangsu Qitian Gene Technology Co., Ltd., China
| | - J F Liu
- National Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi 214064, China.,Public Health Research Center, Jiangnan University, China
| | - X Z Xu
- National Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi 214064, China.,Public Health Research Center, Jiangnan University, China
| | - Q J Ying
- Jiangsu Qitian Gene Technology Co., Ltd., China
| | - J Cao
- National Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi 214064, China.,Public Health Research Center, Jiangnan University, China
| | - Y Dai
- National Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi 214064, China.,Public Health Research Center, Jiangnan University, China
| |
Collapse
|
39
|
Yan WL, Liu JF, Chen K, Wang J, Su SB, Li RZ. [Application of three semi-quantitative risk assessment methods in electroplating enterprises]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2019; 37:420-425. [PMID: 31256522 DOI: 10.3760/cma.j.issn.1001-9391.2019.06.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To apply the semi-quantitative risk assessment model in the Technical Guidelines for Occupational Health Risk Assessment of Chemical Hazardous Factors in the Workplace to assess the occupational health risk of electroplating enterprises and explore its applicable conditions and characteristics. Methods: Three electroplating enterprises were selected as the research objects. Occupational hygiene survey and hazard factor detection were conducted on the spot. Three semi-quantitative risk assessment methods were used to assess the risk, and the evaluation results were compared. Results: The consistency between the contact index method and the comprehensive index method was strong. The weighted Kappa value was 0.946 and the P value was less than 0.001, but the consistency between the contact ratio method, the contact index method and the comprehensive index method was poor. The weighted Kappa value was 0.345 and 0.391, and the P value was 0.009 and 0.004, respectively. When the contact concentration is less than 50% OELs, the evaluation results of the contact ratio method are lower than those of the exponential method and the comprehensive exponential method. The consistency of the three methods was the highest when the contact concentration (>50%) and (<OELs). When the contact concentration >OELs, the results of the contact ratio method are higher than those of the index method and the comprehensive index method. Conclusion: Contact ratio method is suitable for occupational health risk assessment under the condition of incomplete occupational health information and for enterprise managers to identify key control points of health risk through self-assessment; Contact index method is suitable for hazard risk assessment of occupational hazards without sampling test conditions or OELs, and pre-assessment of occupational hazards of construction projects without access to analogical test data. The index method is suitable for occupational health risk assessment with available testing data and complete occupational health information.
Collapse
Affiliation(s)
- W L Yan
- Huizhou Occupational Disease Prevention and Control Hospital, Huizhou 516001, China
| | - J F Liu
- Huizhou Occupational Disease Prevention and Control Hospital, Huizhou 516001, China
| | - K Chen
- Huizhou Occupational Disease Prevention and Control Hospital, Huizhou 516001, China
| | - J Wang
- Huizhou Occupational Disease Prevention and Control Hospital, Huizhou 516001, China
| | - S B Su
- Guangdong Province Hospital for Occupational Disease Prevention and Treatment, Guangzhou 510300, China
| | - R Z Li
- Guangdong Province Hospital for Occupational Disease Prevention and Treatment, Guangzhou 510300, China
| |
Collapse
|
40
|
Wei TT, Wang ZL, Qi Y, Liu JQ, Liu JF, Wei HQ, Ren X. [The application of Chinese version of anterior skull base questionnaire (ASBQ) in patients with anterior and middle skull base tumors]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2019; 54:641-646. [PMID: 31550754 DOI: 10.3760/cma.j.issn.1673-0860.2019.09.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To develop the Chinese version of anterior skull base questionnaire(ASBQ) and to verify its application in patients with anterior and middle skull base tumors. Methods: The following steps were finished including getting the permission from the author of the original English scale, translating and back-translating, tentative test, discussing the consequence and cultural debugging. From October 2016 to December 2018, 51 patients with skull base tumors from Xuanwu Hospital and China-Japan Friendship Hospital were enrolled as an experimental group, aged from 24 to 70 years old, with 19 males and 32 females, which included 27 patients with anterior skull base tumor and 24 patients with middle skull base tumor. From December 2016 to January 2018, 46 healthy volunteers were selected as a control group, aged from 18 to 36 years old, including 26 females and 20 males. The subjects in the test group and the control group were rigorously tested with official manuscripts and judged whether the manuscript was applicable. The SPSS 22.0 statistical software was used to analyze the data of the test group, the anterior skull base group, the middle skull base group and the control group to evaluate the performance of the scale. Results: Both the rate of the recovery and efficiency in experimental group, anterior skull base group and middle skull base group were 100%, with the average time of completion of (8.7±3.2), (11.2±4.0) and (7.3±2.1) min, respectively in each group. The r value of test-retest reliability was 0.96, 0.99 and 0.97 in experimental group, anterior skull base group and middle skull base group, with the split-half reliability coefficient of 0.91, 0.90 and 0.96, with the entire scale Cronbach's coefficient of 0.91, 0.95 and 0.93, respectively. The content validity and the construct validity of the scale were good enough, and the criteria validity was-0.483,-0.509 and -0.489 in experimental group, anterior skull base group and middle skull base group. The scale could well distinguish the difference of the quality of life between the preoperative and postoperative patients in experimental group and the middle skull base group. The difference of the quality of life in anterior skull base group was not found between preoperative and postoperative patients. Conclusion: The Chinese version of ASBQ has good reliability and validity, which is suitable for a wide range of Chinese patients with anterior and middle skull base tumors to assess their quality of life.
Collapse
Affiliation(s)
- T T Wei
- Department of Otorhinolaryngology Head and Neck Surgery, Skull Base Surgery Center, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
| | - Z L Wang
- Department of Otorhinolaryngology Head and Neck Surgery, Skull Base Surgery Center, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
| | - Y Qi
- Department of Otorhinolaryngology Head and Neck Surgery, Skull Base Surgery Center, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
| | - J Q Liu
- Department of Otorhinolaryngology Head and Neck Surgery, Skull Base Surgery Center, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
| | - J F Liu
- Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - H Q Wei
- Department of Otorhinolaryngology Head and Neck Surgery, the First Hospital of China Medical University, Shenyang 110001, China
| | - X Ren
- Department of Otorhinolaryngology Head and Neck Surgery, Skull Base Surgery Center, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
| |
Collapse
|
41
|
Liu JF, Duan XH, Ren JZ, Jiao DC, Han XW. [Comparative effect of CalliSpheres drug loading microspheres and lipiodol transarterial chemoembolization in the treatment of huge primary liver cancer]. Zhonghua Gan Zang Bing Za Zhi 2019; 27:460-462. [PMID: 31357764 DOI: 10.3760/cma.j.issn.1007-3418.2019.06.014] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- J F Liu
- Department of Interventional Radiology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
| | - X H Duan
- Department of Interventional Radiology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
| | - J Z Ren
- Department of Interventional Radiology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
| | - D C Jiao
- Department of Interventional Radiology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
| | - X W Han
- Department of Interventional Radiology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China; Intervention and Clinical Research Center of Henan Province, Zhengzhou 450002, China
| |
Collapse
|
42
|
Liu JF, Wen DH, Li XJ, Liu XY, Xue G. [Diagnostic performance of ultrasound-based risk stratification systems for indeterminate thyroid nodules: comparison of the 2015ATA guidelines with the 2016 KTA/KSThR and 2017ACR guidelines]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2019; 33:388-392;397. [PMID: 31163542 DOI: 10.13201/j.issn.1001-1781.2019.05.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 12/16/2018] [Indexed: 11/12/2022]
Abstract
Objective: To evaluate the diagnostic value of the 2015ATA, 2017ACR and 2016KTA/KSThR ultrasound model for indeterminate thyroids nodules. Method: Four hundred and sixty-four patients with thyroid nodules that were initially diagnosed as indeterminate thyroids nodules by fine needle aspiration(FNA) cytology were included in this study. The clinical data and two-dimensional ultrasonographic features were compared between the benign and malignant nodules. The two-dimensional ultrasound images of all nodules were sorted by the 2015ATA, 2017ACR and 2016KTA/KSThR guideline ultrasound model grading criteria, and the malignant risk of different grading were calculated. In order to calculate the diagnosis and other indicators, the optimal threshold drawing from ROC curve was drawn to obtain the cut-off value of 2015ATA, 2017ACR and 2016KTA/KSThR. Result: ①There was no significant difference in age, sex and nodule size between benign and malignant nodules(P>0.05), and there also was no significant difference in irregular margin, microcalcification between benign and malignant nodules.②The sensitivity of the 2015ATA ultrasound model was 87.9%, slightly lower than that of the 2016KTA/KSThR and 2017ACR guidelines(P>0.05).The specificity of 2015ATA was 63.9%, which was significantly higher than that of 2016KTA/KSThR and 2017ACR guidelines(P<0.05). There was no significant difference between 2015ATA ultrasound model and 2016KTA/KSThR guide ultrasound for the accuracy(P>0.05), but the accuracy of 2015ATA ultrasound model was significantly higher than that of 2017ACR guide(P<0.05).③The area under the curve of 2015ATA was slightly lower than that of 2016KTA/KSThR(0.889 VS 0.902, P>0.05) and significantly higher than that of 2017ACR(0.889 VS 0.854, P<0.05). Conclusion: 2015ATA has high specificity and accuracy and moderate sensitivity for the diagnosis of benign and malignant indeterminate thyroids nodules, which is helpful for the clinical evaluation and management of such nodules.
Collapse
Affiliation(s)
- J F Liu
- Department of Ultrasonography, the First Affiliated Hospital of Hebei North University, Zhangjiakou, 075000, China
| | - D H Wen
- Department of Ultrasonography, the First Affiliated Hospital of Hebei North University, Zhangjiakou, 075000, China
| | - X J Li
- Department of Ultrasonography, the First Affiliated Hospital of Hebei North University, Zhangjiakou, 075000, China
| | - X Y Liu
- Department of Ultrasonography, the First Affiliated Hospital of Hebei North University, Zhangjiakou, 075000, China
| | - G Xue
- Department of Otorhinolaryngology Head and Neck Surgery, the First Affiliated Hospital of Hebei North University
| |
Collapse
|
43
|
Liu JF, Liu XB, Wang Z, Shi ZH, Cao BJ, Jiang T, Zhang SW. [Gastrectomy with either wedge resection of the pancreas or pancreaticosplenectomy for adenocarcinoma of the esophagogastric junction invading the pancreas: a comparison study]. Zhonghua Wai Ke Za Zhi 2019; 57:452-456. [PMID: 31142071 DOI: 10.3760/cma.j.issn.0529-5815.2019.06.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To compare the outcomes of gastrectomy with either wedge resection of the pancreas or pancreaticosplenectomy for adenocarcinoma of the esophagogastric junction (AEG) invading pancreas. Methods: From May 2005 to December 2015, a total of 64 patients with AEG invading pancreas underwent gastrectomy with either wedge resection of pancreas (n=25) or pancreaticosplenectomy (n=39) at Department of Thoracic Surgery, Fourth Hospital, Hebei Medical University. There were 53 males and 11 females, with a mean age of 60.2 years (range: 39 to 77 years). According to the AJCC esophageal cancer staging system, 8(th) edition, there were 27 patients in phase T4N0M0, 18 in phase T4bN1M0, 9 in phase T4bN2M0 and 10 in phase T4bN3M0. Follow-up was carried out every 6 months. The t-test for the measurement data and the χ(2) test, Fisher exact test or Wilcoxon ran-sum test for the enumeration data were used between the two groups. Survival curves were generated using the Kaplan-Meier method, and compared using the Log-rank test. Multivariate analysis was undertaken using the Cox proportional hazard model (forward stepwise regression). Results: In 39 patients who underwent pancreaticosplenectomy, incision infection occurred in 5 patients, anastomotic leak, peritoneal infection, lung infarction each occurred in 1 patient. There was 1 respiratory failure and 1 peritoneal infection in 25 patients undergoing wedge resection of the pancreas. There were no significant difference in the incidence of postoperative complications between the 2 groups (8/39 vs. 2/25, P=0.292), and no postoperative death in the study. Fifty-seven patients were followed up, with a follow-up rate of 89.1%. The 5-year overall survival rate was 32.3% in patients who underwent simultaneous gastrectomy and pancreaticosplenectomy, compared to 0 in those who underwent gastrectomy and wedge resection of the pancreas (χ(2)=4.484, P=0.034). The 5-year overall survival rate for patients who undergoing adjuvant chemotherapy was 32.3%, compared to 17.2% in whom underwent surgery alone (χ(2)=4.186, P=0.041). Conclusions: Survival benefit from R0 resection by simultaneous gastrectomy and pancreaticosplenectomy for AEG invading the pancreas can be achieved. Adjuvant chemotherapy is necessary for these patients.
Collapse
Affiliation(s)
- J F Liu
- Department of Thoracic Surgery, Fourth Hospital, Hebei Medical University, Shijiazhuang 050011, China
| | | | | | | | | | | | | |
Collapse
|
44
|
Zhao L, Sun LF, Zheng XL, Liu JF, Zheng R, Wang Y, Yang R, Zhang L, Yu L, Zhang H. [In vitro fertilization-embryo transfer affects focal adhension kinase signaling pathway in early placenta]. Beijing Da Xue Xue Bao Yi Xue Ban 2019; 51:151-158. [PMID: 30773560 DOI: 10.19723/j.issn.1671-167x.2019.01.026] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
OBJECTIVE To study the effects of in vitro fertilization-embryo transfer (IVF-ET) technique on gene expression of focal adhension kinase (FAK) signaling pathway in early placental trophoblast cells, and to explore the effects of IVF-ET technology on the development and function of early placenta. METHODS We collected 7-8 weeks of gestation placenta tissue as a study group by ultrasound guided reduction of fetal from double embryo transfer under IVF-ET technology. In the control group, placenta tissues were obtained from the spontaneous abortion of natural pregnancy twin 7-8 weeks. Microarray hybridization analysis was performed on the placenta tissue of the two groups using the Affymetrix HG-U133 Plus 2.0 gene chip. Eight differentially expressed genes were identified by real-time quantitative polymerase chain reaction (qRT-PCR), and unsupervised clustering analysis and functional bioinformatics analysis were performed for the differentially expressed genes. RESULTS Twenty-eight cases of IVF-ET reduced fetal villi and 8 cases of spontaneous abortion villi were collected. A total of 8 placental villi were detected by the gene chip. Compared with the natural pregnancy control group, 32 differentially expressed genes in the placental FAK signaling pathway were expressed in IVF-ET. The differential expression was greater than or equal to 2 times, of which 12 genes were up-regulated and 20 were down-regulated. The qRT-PCR showed that the expression of the 8 genes in FAK signaling pathways of IVF-ET was significantly different from that in the placenta of natural pregnancy, which was consistent with the result of the gene chip detection. The FAK signal pathway gene localization showed that the FAK gene was mainly located in the upstream of the signal pathway in the placenta of IVF-ET. The placental trophoblast cells maintained the FAK signaling pathway function through gene expression compensation. CONCLUSION There are gene expression differences in the FAK signaling pathway between the IVF-ET derived early placenta and the natural pregnancy placenta. The differentially expressed genes are involved in many key functions of the FAK signaling pathway and affect the early development and function of the IVF-ET placenta, while the placental trophoblast cells change gene expression for interference to compensate for IVF-ET technology itself, maintain normal function of the FAK signaling pathway, and satisfy the need for placental and fetal development.
Collapse
Affiliation(s)
- L Zhao
- Department of Obstetrics and Gynecology, Beijing Jishuitan Hospital, Beijing 100035, China
| | - L F Sun
- Department of Obstetrics and Gynecology, Beijing Jishuitan Hospital, Beijing 100035, China
| | - X L Zheng
- Department of Obstetrics and Gynecology, Beijing Jishuitan Hospital, Beijing 100035, China
| | - J F Liu
- Department of Obstetrics and Gynecology, Beijing Jishuitan Hospital, Beijing 100035, China
| | - R Zheng
- Department of Obstetrics and Gynecology, Beijing Jishuitan Hospital, Beijing 100035, China
| | - Y Wang
- Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China
| | - R Yang
- Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China
| | - L Zhang
- Department of Obstetrics and Gynecology, Beijing Tsinghua Changgung Hospital, Beijing 102218, China
| | - L Yu
- Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China
| | - H Zhang
- Department of Obstetrics and Gynecology, Beijing Jishuitan Hospital, Beijing 100035, China
| |
Collapse
|
45
|
Liu JF, Barry WT, Birrer M, Lee JM, Buckanovich RJ, Fleming GF, Rimel BJ, Buss MK, Nattam SR, Hurteau J, Luo W, Curtis J, Whalen C, Kohn EC, Ivy SP, Matulonis UA. Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer. Ann Oncol 2019; 30:551-557. [PMID: 30753272 PMCID: PMC6503628 DOI: 10.1093/annonc/mdz018] [Citation(s) in RCA: 122] [Impact Index Per Article: 24.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
BACKGROUND Olaparib is a poly(ADP-ribose) polymerase inhibitor and cediranib is an oral anti-angiogenic. In the primary analysis of this phase II study, combination cediranib/olaparib improved progression-free survival (PFS) compared with olaparib alone in relapsed platinum-sensitive ovarian cancer. This updated analysis was conducted to characterize overall survival (OS) and update PFS outcomes. PATIENTS AND METHODS Ninety patients were enrolled to this randomized, open-label, phase II study between October 2011 and June 2013 across nine United States-based academic centers. Data cut-off was 21 December 2016, with a median follow-up of 46 months. Participants had relapsed platinum-sensitive ovarian cancer of high-grade serous or endometrioid histology or had a deleterious germline BRCA1/2 mutation (gBRCAm). Participants were randomized to receive olaparib capsules 400 mg twice daily or cediranib 30 mg daily and olaparib capsules 200 mg twice daily until disease progression. RESULTS In this updated analysis, median PFS remained significantly longer with cediranib/olaparib compared with olaparib alone (16.5 versus 8.2 months, hazard ratio 0.50; P = 0.007). Subset analyses within stratum defined by BRCA status demonstrated statistically significant improvement in PFS (23.7 versus 5.7 months, P = 0.002) and OS (37.8 versus 23.0 months, P = 0.047) in gBRCA wild-type/unknown patients, although OS was not statistically different in the overall study population (44.2 versus 33.3 months, hazard ratio 0.64; P = 0.11). PFS and OS appeared similar between the two arms in gBRCAm patients. The most common CTCAE grade 3/4 adverse events with cediranib/olaparib remained fatigue, diarrhea, and hypertension. CONCLUSIONS Combination cediranib/olaparib significantly extends PFS compared with olaparib alone in relapsed platinum-sensitive ovarian cancer. Subset analyses suggest this margin of benefit is driven by PFS prolongation in patients without gBRCAm. OS was also significantly increased by the cediranib/olaparib combination in this subset of patients. Additional studies of this combination are ongoing and should incorporate analyses based upon BRCA status. TRIAL REGISTRATION Clinicaltrials.gov Identifier NCT0111648.
Collapse
Affiliation(s)
- J F Liu
- Division of Gynecologic Oncology, Department of Medical Oncology.
| | - W T Barry
- Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston
| | - M Birrer
- Department of Medical Oncology, Massachusetts General Hospital, Boston
| | - J-M Lee
- Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda
| | - R J Buckanovich
- Department of Internal Medicine, University of Pittsburgh Hillman Cancer Center, Pittsburgh
| | - G F Fleming
- Section of Hematology/Oncology, University of Chicago, Chicago
| | - B J Rimel
- Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles
| | - M K Buss
- Division of Hematology/Oncology, Beth-Israel Deaconess Medical Center, Boston
| | - S R Nattam
- Department of Oncology, Fort Wayne Medical Oncology and Hematology, Fort Wayne
| | - J Hurteau
- Division of Gynecologic Oncology, NorthShore University HealthSystem, Evanston Hospital, Evanston
| | - W Luo
- Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston
| | - J Curtis
- Division of Gynecologic Oncology, Department of Medical Oncology
| | - C Whalen
- Division of Gynecologic Oncology, Department of Medical Oncology
| | - E C Kohn
- Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, USA
| | - S P Ivy
- Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, USA
| | - U A Matulonis
- Division of Gynecologic Oncology, Department of Medical Oncology
| |
Collapse
|
46
|
Zheng YM, Liu DB, Wang YH, Liu JF, Liu LW, Bai XS, Li F. [Operative method choice and strategy of laparoscopic surgery therapy for gallbladder stones and common bile duct stones]. Zhonghua Wai Ke Za Zhi 2019; 57:282-287. [PMID: 30929374 DOI: 10.3760/cma.j.issn.0529-5815.2019.04.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the selection method and technology of laparoscopic surgery for gallbladder stones and common bile duct stones(GCBDS). Methods: Data was collected from 318 in-patients of GCBDS at Department of General Surgery,Xuanwu Hospital of Capital Medical University from January 2013 to December 2017, and 298 in-patients acceptedlaparoscopic cholecystectomy(LC) and choledocholithotomy were recruited into final analysis.There were 138 males and 160 females,aged (60.4±18.6)years (range:25-89 years).Retrospective analysis was done on method distribution,effect and safety of laproscopic surgery.Comparisons of basic characters and therapeutic effects were performed betweenlaparoscopic common bile duct exploration (LCBDE) combined with primary closure and T tube drainage(TTD). Results: Among therecruited in-patients,LC combined with common bile duct exploration was performed in 7 cases(2.3%, 7/298), LC combined with LCBDE was performed in 291 cases(97.7%,291/298).There were 133 cases (45.7%,133/291) who treated by LCBDE combined with TTD and 158 cases(54.3%,158/291) who treated by LCBDE combined with primary closure.In LCBDE combined with primary closure group,18 cases (11.4%,18/158)had intraoperative biliary manometry.All patients were followed up for 6 months at least and there no death.Postoperative complications rate was 10.0% (29/291).There were no significant differences in sex ratio,age,American Society of Anesthesiologists score,concomitant diseases and previous abdominal surgery history between LCBDE combined with primary closure and LCBDE combined with TTD group.Patients in LCBDE combined with primary closure group were accompanied with less acute cholangitis than TTD group (43.3% vs.76.7%; χ(2)=9.061, P=0.002).There were no significant differences in the diameter of common bile duct, the number of stones, hospitalization expenses and the incidence of complications between the two groups(all P>0.05).LCBDE combined with primary closure had shorter operation time ((134.2±28.3)minutes vs.(148.3±19.6)minutes; t=-1.830, P=0.011)and post-operative hospitalization time ((5.6±2.6)days vs. (7.2±2.4)days; t=-1.847,P=0.014).Bile duct leakage rate was higher in primary closure group(6.3% vs.0.8%, χ(2)=3.934, P=0.047) and TTD group had higher residual stones rate(6.8% vs.1.3%; χ(2)=6.008, P=0.014). Conclusion: Strategy for treating GCBDS by laparoscopic surgery should be considered preoperative evaluation and intraoperative exploration to select appropriate minimally invasive surgical methods and techniques.
Collapse
Affiliation(s)
- Y M Zheng
- Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
| | - D B Liu
- Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
| | - Y H Wang
- Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
| | - J F Liu
- Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
| | - L W Liu
- The First Clinical Medical College, Capital Medical University, Beijing 100053, China
| | - X S Bai
- The First Clinical Medical College, Capital Medical University, Beijing 100053, China
| | - F Li
- Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
| |
Collapse
|
47
|
Liu JF, Wang J, Guo DD, Qi CJ, Cao FR, Tian Z, Yao NJ, Wu YC, Yang Y, He YL, Zhao YR, Chen TY. [Predictive value of single nucleotide polymorphisms of HLA-C and UBE2L3 in evaluating the effect of telbivudine antiviral therapy during pregnancy]. Zhonghua Gan Zang Bing Za Zhi 2019; 25:601-605. [PMID: 29056010 DOI: 10.3760/cma.j.issn.1007-3418.2017.08.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the association between single nucleotide polymorphisms (SNPs) of rs3130542 and rs4821116 in the HLA-C and UBE2L3 genes and the effect of telbivudine antiviral therapy during pregnancy in HBeAg-positive mothers through a large-sample control study, and to provide a basis for the development of individualized blocking strategies for pregnant women with a high viral load. Methods: The genotypes of rs3130542 and rs4821116 were determined for 312 pregnant women with a high viral load who received telbivudine antiviral therapy during the second or third trimester of pregnancy, and the dominant model, recessive model, and additive model were used to analyze the association between the genotypes of these two loci and the reduction in HBV DNA load. The Shapiro-Wilk test and the Levene test were used to evaluate data normality and homogeneity of variances, and the t-test or the non-parametric Mann-Whitney U test was selected based on data type and was used for the comparison of means between groups. The Hardy-Weinberg equilibrium was used to determine the genotype of SNPs, and the dominant model, recessive model, and additive model were used for analysis. Results: Mothers with an AA/AG genotype of rs3130542 in the HLA-C gene had a significantly higher probability of HBV DNA load ≥10(3) IU/ml at the time of delivery (P < 0.05) and a significantly higher risk of failure in the prevention of mother-to-child transmission, no matter whether they started to take telbivudine at week 24 or 28 of pregnancy. The association between the genotype of rs4821116 in the UBE2L3 gene and the reduction in viral load in pregnant women needed to be confirmed by studies with a larger sample size. Conclusion: Pregnant women with a high viral load and an AA/AG genotype of rs3130542 in the HLA-C gene tend to have poor response to antiviral therapy during pregnancy, and early antiviral intervention is recommended for such patients.
Collapse
Affiliation(s)
- J F Liu
- Department of Infectious Disease, the First Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710061, China
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Dong Z, Liu JF. [The applications of "Lacha" in Sheng Ji Zonglu]. Zhonghua Yi Shi Za Zhi 2019; 49:25-28. [PMID: 30970421 DOI: 10.3760/cma.j.issn.0255-7053.2019.01.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
The earliest appearance of "Lacha" was in the Tang Dynasty. At first, it was only served as a type of tribute tea to the emperor and the royal families.Since the Song Dynasty, "Lacha" was viewed as a kind of medicine or drug.Sheng Ji Zonglu(, Comprehensive Record of Sagely Beneficence) is the most abundant literature of the medicinal formulas of "Lacha" since the Song Dynasty. The book presented 72 prescriptions, which involved 62 diseases.Its application forms were diverse, including decoction, pill, powder and so on.The main functions included resuscitating, clearing up the heads, aiding digestion, dissipating phlegm, detoxifying and treating sores, eliminating miasma, and reducing the toxicity of other drugs.
Collapse
Affiliation(s)
- Z Dong
- China Institute for History of Medicine and Medical Literature, China Academy of Chinese Medical Sciences, Beijing 100700, China
| | | |
Collapse
|
49
|
Liu JY, Liu QT, Yan ZF, Liu JF. [The measurement of pneumatization of maxillary sinus extended into alveolar process basing on the CT and its clinical significance]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2018; 31:1161-1164. [PMID: 29798349 DOI: 10.13201/j.issn.1001-1781.2017.15.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 05/12/2017] [Indexed: 11/12/2022]
Abstract
Objective:To investigate the significance of pneumatization of maxillary sinus extended into alveolar process.Method:One hundred outpatients encountered were included in this study. The pneumatizations of maxillary sinus extended into alveolar process were observed and classified. Depth of surgical procedure of maxillary sinus in different type was measured.Result:The actual depth of surgical procedure of maxillary sinus of in different types of the alveolar process pneumatization varied greatly. The actual depth of surgical procedure of maxillary sinus in type Ⅲ pneumatization of alveolar process were (32.27±3.48)mm, which were significantly deeper than type Ⅱ (28.35±3.45)mm and type Ⅰ(20.73±3.09)mm (P< 0.05 respectively). Moreover, the actual depth of surgical procedure of maxillary sinus in type Ⅱ was also deeper than type Ⅰ(P< 0.05).Conclusion:The pneumatization of maxillary sinus extended into alveolar process can significantly affect the actual depth of the maxillary sinus in the operation of endoscopic middle meatus antrostomy, which may serve as a reference for the choice of endoscopic maxillary sinus approaches.
Collapse
Affiliation(s)
- J Y Liu
- Department of Neurosurgery, Baota District People's Hospital of Yan'an Shaanxi Province, Yan'an, 716000, China
| | - Q T Liu
- Department of Radiology, Beijing Chaoyang Hospital, Capital Medical University
| | - Z F Yan
- Department of Otolaryngology, Dongzhimen Hospital, Beijing University of Chinese Medicine
| | - J F Liu
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University
| |
Collapse
|
50
|
Liu JF, Han J, Han HL, Zhao JH. [Present status of the treatment for olfactory dysfunction]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2018; 53:544-549. [PMID: 30032501 DOI: 10.3760/cma.j.issn.1673-0860.2018.07.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Olfactory dysfunction is defined as decrease or loss of smell perception.This review systematically summarizes classification, etiology and diagnosis progress of olfactory dysfunction, and focuses on advancement in management of olfactory dysfunction, including pharmaceutical remedy, surgical treatment as well as olfactory training.Glucocorticoids play an important role in the treatment of olfactory dysfunction. Sodium citrate, vitamin A, and nonspecific phosphodiesterase inhibitors (theophylline, pentoxifylline) are promising drugs.Endoscopic paranasal sinuses surgery can improve the olfactory dysfunction caused by chronic sinusitis to some extent.Olfactory training has been proven to be effective for a variety of causes of olfactory dysfunction.
Collapse
Affiliation(s)
- J F Liu
- Department of Otorhinolaryngology, China-Japan Friendship Hospital, Beijing 100029, China
| | - J Han
- Department of Otorhinolaryngology, China-Japan Friendship Hospital, Beijing 100029, China
| | - H L Han
- Department of Otorhinolaryngology, China-Japan Friendship Hospital, Beijing 100029, China
| | - J H Zhao
- Department of Otorhinolaryngology, China-Japan Friendship Hospital, Beijing 100029, China
| |
Collapse
|